syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.07941569	100.0
SMITH-MAGENIS SYNDROME; SMS	5.127454474	63.46318435312494
PANDAS	2.6298768100000007	32.55033421853803
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.2147148500000005	27.411819554490584
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.99228753013945
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930266
NARCOLEPSY 1; NRCLP1	1.8373013	22.74052196960298
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.42459584	17.632411731992466
TRICHOTHIODYSTROPHY	1.227942884	15.198412002984835
BRAIN-LUNG-THYROID SYNDROME	1.221783774	15.122179881302777
16P12.1P12.3 TRIPLICATION SYNDROME	1.2215289	15.119025271987214
CITRULLINEMIA TYPE II	1.188060604	14.704783731705726
MOWAT-WILSON SYNDROME; MOWS	1.1169643	13.824815343793755
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.1105442	13.745352914252642
SCHIZOPHRENIA	1.0894928	13.484796943279942
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933898
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	1.04261392	12.904570825467701
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.00740741	12.46881517987596
CHAR SYNDROME	1.000545554	12.383885077709127
PLUMMER-VINSON SYNDROME	1.0	12.377132683465133
KIFAFA SEIZURE DISORDER	1.0	12.377132683465133
RETINITIS PIGMENTOSA 75; RP75	1.0	12.377132683465133
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	12.377132683465133
EHLERS-DANLOS SYNDROME, TYPE I	1.0	12.377132683465133
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	12.377132683465133
TARDIVE DYSKINESIA	1.0	12.377132683465133
7Q11.23 MICRODUPLICATION SYNDROME	0.87584354	10.840431704535803
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.8490228000000001	10.508467846887083
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137846
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328385
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.78174704	9.675786838986125
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.74627125	9.236698279105381
CRI-DU-CHAT SYNDROME	0.7166162799999999	8.869654780691201
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609603
POSTENCEPHALITIC PARKINSONISM	0.7008730400000001	8.674798610343567
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505	8.221516573558056
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.6614567399999999	8.186937835352298
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772607
48,XXXY SYNDROME	0.626612904	7.7556710539794
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.65202811343403
XQ12-Q13.3 DUPLICATION SYNDROME	0.57218761	7.082041968804802
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.56415163	6.982579578103129
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.9167446191891635
15Q OVERGROWTH SYNDROME	0.55616517	6.883730103011942
MOMO SYNDROME	0.54952505	6.801544456737811
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5492597	6.798260184580254
COG5-CDG	0.54119421	6.698432544693094
BRACHYDACTYLY TYPE A2	0.537037	6.646978204930065
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.536589064	6.641434041624364
MANGANESE POISONING	0.53548949	6.6278244683310765
NON-DISTAL MONOSOMY 20Q	0.52568125	6.506426580459807
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52487445	6.496440709810786
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52487445	6.496440709810786
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52487445	6.496440709810786
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.5172414	6.4019654371812615
CHROMOSOME 1P36 DELETION SYNDROME	0.517214754	6.401635636103779
ZUNICH NEUROECTODERMAL SYNDROME	0.51640336	6.3915929049072115
RING CHROMOSOME 13 SYNDROME	0.51073229	6.3214013190599925
WILLIAMS-BEUREN SYNDROME; WBS	0.51001775	6.312557362672351
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.506101114	6.2640806392275135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.502714754	6.2221672121935345
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5021692	6.21541481794954
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5021692	6.21541481794954
SPONDYLOPERIPHERAL DYSPLASIA	0.50204918	6.21392931448487
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	6.195318735976562
W SYNDROME	0.500545554	6.195318735976562
BRACHYDACTYLY, TYPE D	0.5	6.1885663417325665
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.1885663417325665
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.1885663417325665
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	6.1885663417325665
613241 PSEUDOPILI ANNULATI	0.5	6.1885663417325665
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.5	6.1885663417325665
BRACHYDACTYLY TYPE C	0.5	6.1885663417325665
SEMANTIC DEMENTIA	0.5	6.1885663417325665
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	6.1885663417325665
MADELUNG DEFORMITY	0.5	6.1885663417325665
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.1885663417325665
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	6.1885663417325665
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.016818154333634
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.47607424400000004	5.892434085168356
16P13.2 MICRODELETION SYNDROME	0.4624678240000001	5.724025619481402
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.461298714	5.709555389889835
MUCOPOLYSACCHARIDOSIS TYPE 2	0.458526824	5.675247339575865
CONGENITAL MYASTHENIC SYNDROME	0.45476170000000005	5.628645900258167
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.45476170000000005	5.628645900258167
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.44987445000000004	5.568155758550901
AUTISM	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.568155758550901
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.44987445000000004	5.568155758550901
WILLIAMS SYNDROME	0.44665295000000005	5.528282825611119
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.4428322	5.480992895910769
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.433169264	5.361393454926937
PRADER-WILLI SYNDROME	0.43041703000000003	5.327328689532994
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574126
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.406447524	5.030654933413879
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.0097880283716405
CHILDHOOD DISINTEGRATIVE DISORDER	0.39708261	4.91474415026664
11Q22.2Q22.3 MICRODELETION SYNDROME	0.39644612399999996	4.906866278593471
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338742
MONOSOMY 22Q13.3	0.393769224	4.873733932113103
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.3888886	4.813325801286998
PLACENTAL INSUFFICIENCY	0.38385355	4.751006319369118
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.37821725	4.681245086425304
CHRISTIANSON SYNDROME	0.36596514	4.529599095302894
CHROMOSOME 17Q12 DELETION SYNDROME	0.36537525000000004	4.522297948504245
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.438032572625311
49,XXXXY SYNDROME	0.354262894	4.3847588438663445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.352702394	4.365444328313797
ADNP SYNDROME	0.35143281	4.349730518692993
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852048
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829093
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.34453514999999996	4.264357265667562
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.34364421399999995	4.253330032583086
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
POLAND SYNDROME	0.34226157	4.23621686434109
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.34226157	4.23621686434109
ANGELMAN SYNDROME	0.34030843400000005	4.212042640920238
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
SPINOCEREBELLAR ATAXIA TYPE 42	0.33777744	4.180716192361182
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.337568594	4.178131277708772
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33702304	4.171378883464777
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	4.1257067687774835
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	4.1257067687774835
ISOLATED CLEFT LIP	0.333333	4.1257067687774835
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	4.1257067687774835
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	4.1257067687774835
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	4.1257067687774835
MAST SYNDROME	0.333333	4.1257067687774835
BRACHYDACTYLY, TYPE A6	0.333333	4.1257067687774835
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.06953810294665
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.32573161	4.031623356168718
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.31839112399999997	3.9407691869856003
DUPLICATION/INVERSION 15Q11	0.31697817	3.9232808678519673
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.8560376387812774
GITELMAN SYNDROME	0.31040850000000003	3.841967190575388
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.304561894	3.769602972365443
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.30326199000000004	3.753513888081677
OROMANDIBULAR DYSTONIA	0.29989924	3.7118926851503544
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.296450364	3.6692054892895363
2Q23.1 MICRODELETION SYNDROME	0.29409525	3.640055930826849
MYOCLONUS-DYSTONIA SYNDROME	0.29335654999999994	3.630912942913573
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29239448000000007	3.6190052748727934
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.29190447	3.612940356086568
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882257
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882257
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.287607014	3.5597501729732146
21Q22.11Q22.12 MICRODELETION SYNDROME	0.2869586	3.5517246668613978
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28283142	3.5006420123928543
1P21.3 MICRODELETION SYNDROME	0.282549214	3.497149111286784
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.27767455999999996	3.4368148719427998
HYPERTRYPTOPHANEMIA; HYPTRP	0.277273234	3.4318476067914756
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.27397014	3.390964774087518
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.27339140999999995	3.383801756089616
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.262981554	3.2549575871618512
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25921145	3.2082945097233884
WILSON DISEASE	0.25918378	3.207952034462037
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25892857	3.20479326642989
ESOPHAGEAL ATRESIA	0.25773862	3.1900650973932
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25704225	3.181446033506416
CHOANAL ATRESIA	0.25613719999999995	3.170244109571245
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25369004	3.1399552855535773
PRADER-WILLI-LIKE SYNDROME	0.25302383400000006	3.1317095654970575
PALLISTER-HALL SYNDROME	0.252594734	3.126398537862582
LYSINURIC PROTEIN INTOLERANCE	0.2521692	3.121131647083256
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	3.1010355651102786
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.1010355651102786
SEVERE HEMOPHILIA A	0.25	3.0942831708662832
DYSTONIA 6, TORSION	0.25	3.0942831708662832
GLOMUVENOUS MALFORMATION	0.25	3.0942831708662832
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	3.0942831708662832
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	3.0942831708662832
HYPERPARATHYROIDISM 2	0.25	3.0942831708662832
HEMOPHILIA B	0.25	3.0942831708662832
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	3.0942831708662832
CONGENITAL FACTOR II DEFICIENCY	0.25	3.0942831708662832
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25	3.0942831708662832
UVEAL MELANOMA	0.25	3.0942831708662832
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	3.0942831708662832
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.0037189483934084
8Q24.3 MICRODELETION SYNDROME	0.24230595400000005	2.9990529426515997
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.951124550938906
SPASTIC PARAPLEGIA 16, X-LINKED	0.2380341	2.946179638889208
ADENYLOSUCCINASE DEFICIENCY	0.23648485400000002	2.9270044155878807
SAY-BARBER-MILLER SYNDROME	0.23548559400000002	2.914636441982601
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.8746893205095136
PITT-HOPKINS SYNDROME	0.22731774400000002	2.8135418787939606
PITT-HOPKINS-LIKE SYNDROME	0.22695584000000005	2.809062544967284
NARCOLEPSY 7; NRCLP7	0.2261903	2.799587354812784
PHELAN-MCDERMID SYNDROME	0.225907304	2.7960846757718936
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116804
POPOV-CHANG SYNDROME; POPCHAS	0.22520261400000002	2.787362634141183
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.7789262072242757
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.7535408318618155
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.220953754	2.734773930167715
CLEFT VELUM	0.2208333	2.733283055027461
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2204082	2.72802153592372
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.219470304	2.716413072688429
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.21927926399999997	2.7140485452605794
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417225
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.21607024400000005	2.674330078936687
CHROMOSOME 16P13.3 DELETION SYNDROME	0.215530554	2.667650264198747
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472003999999997	2.6576184248789403
SCHIZOPHRENIA 10	0.21449279999999998	2.65480584524795
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344058
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.591407077360071
NARCOLEPSY TYPE 1	0.2089371	2.586042209198423
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.5839978781930952
KEPPEN-LUBINSKY SYNDROME	0.20740741000000001	2.5671090331038533
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.5556531304060184
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.5460857306130267
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.5460857306130267
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.20479756999999998	2.534806697141238
VELOCARDIOFACIAL SYNDROME	0.2047392	2.534084243906505
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767263
BROOKE-SPIEGLER SYNDROME	0.203704	2.5212714361525816
APNEA, OBSTRUCTIVE SLEEP	0.20368649999999996	2.5210548363306207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.2034824	2.518528663549926
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.202714754	2.509027407153994
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	2.5022750129099998
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	2.5022750129099998
CARPENTER SYNDROME	0.20204918000000002	2.50078950944533
HSD10 DISEASE	0.20170466400000003	2.4965253892017536
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.20054555400000001	2.482178930937022
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.20054555400000001	2.482178930937022
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	2.475426536693027
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	2.475426536693027
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.475426536693027
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	2.475426536693027
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	2.475426536693027
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.475426536693027
LINEAR VERRUCOUS NEVUS SYNDROME	0.2	2.475426536693027
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.475426536693027
ROMANO-WARD SYNDROME	0.2	2.475426536693027
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.2	2.475426536693027
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.2	2.475426536693027
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	2.475426536693027
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.19972939399999998	2.4720772103260846
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781036
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.197928414	2.449786241905818
PROGRESSIVE NON-FLUENT APHASIA	0.19787205000000002	2.4490886171992474
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.4338091706728364
TURNER SYNDROME	0.19660314	2.433383149765872
MONOSOMY X	0.19660314	2.433383149765872
MOSAIC MONOSOMY X	0.19660314	2.433383149765872
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19660314	2.433383149765872
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.19535468	2.417930794695873
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.19457093000000003	2.4082302169552072
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1938224	2.3989655618276524
8Q22.1 MICRODELETION SYNDROME	0.193053694	2.389451185671077
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.378470886673737
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18998064000000003	2.351415588569624
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.187620754	2.3222069664297718
GITELMAN SYNDROME	0.1870752	2.315454572185777
KOOLEN-DE VRIES SYNDROME; KDVS	0.186832944	2.312456137530411
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521454
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18645467	2.307774190041706
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.18527559999999998	2.2931806842086124
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263573
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263573
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184875444	2.288227900302528
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.184564554	2.2843799735225656
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.18445289	2.2829978933785995
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.275064275099825
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.263245351100384
WITTEVEEN-KOLK SYNDROME	0.181992764	2.252548587458557
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.181802944	2.2501991601325813
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1813081	2.2440744102869647
KOOLEN-DE VRIES SYNDROME	0.180350264	2.2322191470259654
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.18021894	2.2305937324534417
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.18021894	2.2305937324534417
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.17700351000000003	2.190795928709048
PFAPA SYNDROME	0.17543893000000002	2.171430914455152
INSULINOMA	0.17526791	2.1693141772236255
2Q32Q33 MICRODELETION SYNDROME	0.174990314	2.1658783346992267
AURICULOCONDYLAR SYNDROME	0.174143154	2.155392922975102
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090653
TRIGEMINAL NEURALGIA	0.17328064	2.144717472755756
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286090999999998	2.1395224188545248
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17275576	2.138220963352859
XIA-GIBBS SYNDROME	0.17197395399999998	2.1285444467581294
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.1282714072111326
PEMPHIGUS VULGARIS	0.17071558	2.112969384794707
WAARDENBURG SYNDROME	0.17035704000000002	2.1085316876423774
268650 RUDIGER SYNDROME	0.17020057000000002	2.1065950376913958
ROIFMAN SYNDROME; RFMN	0.16926173400000002	2.094974939951382
CHROMOSOME 16P13.2 DELETION SYNDROME	0.16909544400000004	2.0929167465574485
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.16871618000000002	2.088222545707387
BRACHYDACTYLY, TYPE E	0.16871618000000002	2.088222545707387
17Q24.2 MICRODELETION SYNDROME	0.16868845	2.087879327818074
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.168367964	2.083912630072881
MCLEOD SYNDROME; MCLDS	0.16835655	2.083771357480432
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.077588360848407
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.166739764	2.063760182637663
BRACHYDACTYLY, TYPE B1	0.166667	2.062859572955084
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	2.062859572955084
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	2.062859572955084
247150 LIP PRINTS	0.166667	2.062859572955084
BRACHYDACTYLY TYPE B	0.166667	2.062859572955084
PARAGANGLIOMAS 4	0.166667	2.062859572955084
ACUTE ADRENAL INSUFFICIENCY	0.166667	2.062859572955084
XANTHOMA DISSEMINATUM	0.166667	2.062859572955084
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.062859572955084
SOLAR URTICARIA	0.166667	2.062859572955084
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	2.062859572955084
PARAGANGLIOMAS 3	0.166667	2.062859572955084
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	2.062859572955084
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.166667	2.062859572955084
PHLEBECTASIA OF LIPS	0.166667	2.062859572955084
BRACHYDACTYLY TYPE E	0.166667	2.062859572955084
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.166667	2.062859572955084
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	2.062859572955084
PARAGANGLIOMAS 1	0.166667	2.062859572955084
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	2.062859572955084
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	2.062859572955084
BRACHYDACTYLY TYPE B2	0.166667	2.062859572955084
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	2.062859572955084
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	2.062859572955084
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	2.062859572955084
HOLT-ORAM SYNDROME	0.166667	2.062859572955084
SCALP-EAR-NIPPLE SYNDROME	0.166667	2.062859572955084
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	2.062859572955084
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.062859572955084
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	2.062859572955084
ADDISON DISEASE	0.166667	2.062859572955084
PITYRIASIS RUBRA PILARIS	0.166667	2.062859572955084
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.16542486	2.0474854413636443
MELAS	0.16541866000000002	2.0474087031410066
PERRY SYNDROME	0.16532722	2.0462769381284307
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515104
MYOTONIC DYSTROPHY 1	0.16430498000000002	2.0336245380140854
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.16300838	2.0175763477767044
SPINOCEREBELLAR ATAXIA TYPE 7	0.162165404	2.0071427219757276
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16208779999999998	2.0061822069709594
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.981559139210474
AUTOIMMUNE HYPOPARATHYROIDISM	0.15893896	1.9672085964919575
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15893896	1.9672085964919575
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.9449760481379565
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.156618924	1.9384932030895419
CHRONIC HICCUP	0.15454781999999997	1.912858874080286
LENNOX-GASTAUT SYNDROME	0.15430775	1.909887495836967
DRAVET SYNDROME	0.15188942	1.8799555045545628
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15032022	1.8605333079476694
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14745177399999998	1.8250301712103143
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454781
49,XYYYY SYNDROME	0.14485067000000001	1.7928359618788228
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001189
DE BARSY SYNDROME	0.143402554	1.7749124380057737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.7749124380057737
WRINKLY SKIN SYNDROME	0.143402554	1.7749124380057737
3Q27.3 MICRODELETION SYNDROME	0.1432077	1.7725007041938696
EHLERS-DANLOS SYNDROME, TYPE VI	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617784
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	1.7681600437617784
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.14285699999999998	1.7681600437617784
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617784
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617784
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617784
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	1.7681600437617784
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617784
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	1.7681600437617784
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617784
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	1.7681600437617784
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	1.7681600437617784
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.14285699999999998	1.7681600437617784
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	1.7681600437617784
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617784
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.14193979399999998	1.756807663401708
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971428
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525000000003	1.719496252333565
ADRENOCORTICAL CARCINOMA	0.13663752	1.691180714579621
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13647167	1.689127967124068
USHER SYNDROME	0.13582966000000002	1.681181724169957
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.13498865	1.6707724318118355
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13293112	1.645306110001626
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1326971	1.6424096134110413
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.13138522000000002	1.6261723005862574
SYDENHAM CHOREA	0.13129341	1.625035956034588
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.6232720908558675
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.130438554	1.614455289897332
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.6081127025164863
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668082
SMITH-MAGENIS SYNDROME	0.129273884	1.6000400147748803
49,XXXYY SYNDROME	0.12899125	1.596541816256022
TONNE-KALSCHEUER SYNDROME; TOKAS	0.128194914	1.586685459923402
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12790654	1.5831162166629407
LUSCAN-LUMISH SYNDROME; LLS	0.127062314	1.5726671194461097
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.12591117000000002	1.5584192574203348
BRUNNER SYNDROME; BRNRS	0.12551649	1.553534250692825
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.12522982	1.5499860980664555
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331416
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.5471415854331416
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331416
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331416
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331416
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.12481703400000001	1.544876990974579
SMITH-FINEMAN-MYERS SYNDROME	0.12407411	1.5356817220528483
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.12393006399999999	1.5338988455983258
CHILDHOOD APRAXIA OF SPEECH	0.12316631	1.5244457610027986
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.521784553704527
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.521784553704527
DIASTEMA, DENTAL MEDIAL	0.1222223	1.5127616239782806
FG SYNDROME TYPE 1	0.121751194	1.5069306825083042
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511916
MOHR-TRANEBJAERG SYNDROME	0.11965903000000001	1.481035691084735
NOONAN SYNDROME 7; NS7	0.11913691000000001	1.4745733425680443
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.11890293399999999	1.4716773905712977
ROLANDIC EPILEPSY	0.11662072999999999	1.4434302488525628
MACULAR CORNEAL DYSTROPHY	0.11565645	1.431495227348551
48,XYYY SYNDROME	0.115104494	1.4246635947011164
WIEDEMANN-STEINER SYNDROME	0.11507355000000001	1.4242805967073593
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.11482948400000001	1.4212597594418368
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.114782834	1.420682366202153
MUCOLIPIDOSIS III ALPHA/BETA	0.11464456999999999	1.4189710543288063
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000002	1.4189032771502321
DISTAL MONOSOMY 12Q	0.11433558400000002	1.4151466936094734
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153126
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.11347775	1.4045291683710857
SOMATOMAMMOTROPINOMA	0.11316602000000002	1.4006708447996694
ACROMEGALY	0.11316602000000002	1.4006708447996694
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11316017999999999	1.4005985623447974
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.113045554	1.3991798211338229
KBG SYNDROME	0.112859754	1.396880149881235
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232784999999999	1.390296703498369
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.112159724	1.3882157856888289
RING CHROMOSOME 22 SYNDROME	0.11212498400000001	1.3877858040994053
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.11210831000000002	1.3875794277890414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.112059924	1.3869805478470192
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.11189495	1.3849386427596972
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189495	1.3849386427596972
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189495	1.3849386427596972
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	1.3819879838364895
15Q13.3 MICRODELETION SYNDROME	0.111284584	1.3773840617922213
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.11111099999999999	1.3752355895924944
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11111099999999999	1.3752355895924944
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924944
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.110422544	1.3667144783337668
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10973714	1.358231142083989
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10840336	1.341722770053437
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.106010034	1.31210025659665
TETRASOMY 9P	0.10589082400000001	1.3106247786094543
DEMENTIA, LEWY BODY; DLB	0.1055556	1.3064756666827724
BECKWITH-WIEDEMANN SYNDROME	0.10533855	1.3037892100338262
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.105284894	1.3031251026025623
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.2947706123040195
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179647
HUNTINGTON DISEASE-LIKE 1	0.10444444	1.2927226919302133
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.28106855707532
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.2785833030952762
RAMOS-ARROYO SYNDROME	0.10325498000000001	1.278000587688539
MYASTHENIA GRAVIS	0.1029573	1.2743161628313249
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.2694660596179823
22Q11.2 DELETION SYNDROME	0.10248147399999998	1.2684268012950821
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.102474964	1.268346226161313
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.102448244	1.2680155091760106
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.100682934	1.2461660330785629
SPINOCEREBELLAR ATAXIA TYPE 29	0.10054555400000001	1.2444656625905086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10054555400000001	1.2444656625905086
PSEUDOAMINOPTERIN SYNDROME	0.10035113400000001	1.2420593004541893
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10033526400000001	1.2418628753585026
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.099204054	1.2278617390956401
POSTORGASMIC ILLNESS SYNDROME	0.09903460000000001	1.2257643844538963
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0981997	1.215430716376471
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059288
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	1.2099439334578912
TRISOMY 8P	0.09690986	1.1994661955560304
ERMINE PHENOTYPE	0.09688776000000002	1.1991926609237262
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.181453630590457
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09537729400000002	1.180497422827863
RAYNAUD-CLAES SYNDROME; MRXSRC	0.095255854	1.1789943438347832
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.09507361400000001	1.1767387351745486
AMISH INFANTILE EPILEPSY SYNDROME	0.09445241000000001	1.1690500108430493
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.09424558000000001	1.1664900484901282
ABLEPHARON-MACROSTOMIA SYNDROME	0.0940171	1.1636621212146099
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302325
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09290991000000001	1.1499582836788043
HYPERTRICHOSIS CUBITI	0.09219245400000001	1.141078235572256
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.09175435400000001	1.13565581374363
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166454000000002	1.1345441739487974
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0912088	1.1289034194996348
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344004
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344004
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09074071000000002	1.1231098074618318
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09057968000000001	1.1211167177858132
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.090013394	1.1141077208270245
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.1076642598148088
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.08925809400000001	1.1047592725112032
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.0961265442699362
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08825228999999998	1.092310302949643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630587
GABRIELE-DE VRIES SYNDROME	0.08806046	1.089935997586974
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08786423000000002	1.087507232840498
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.087445520456938
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.08768959000000001	1.0853456903886576
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.087528834	1.0833559920469944
KBG SYNDROME	0.087251924	1.0799286402356159
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.08713383400000001	1.0784670246370256
47,XYY SYNDROME	0.08701528	1.07699966604887
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100154
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.08674443000000001	1.0736473196615537
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08604805400000001	1.0650281815119729
PRADER-WILLI SYNDROME; PWS	0.085997884	1.0644072207652433
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.08596167400000002	1.0639590447907752
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08538248000000001	1.0567902838033083
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08538078999999998	1.056769366449073
LAFORA DISEASE	0.08479032	1.0494610409134675
3Q29 MICRODELETION SYNDROME	0.084664874	1.0479083791268575
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534556
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08439329	1.0445469479241511
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853624
1P36 DELETION SYNDROME	0.084037864	1.040147793162998
RETT SYNDROME, CONGENITAL VARIANT	0.08399551000000001	1.0396235720853226
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950004
PRIMROSE SYNDROME; PRIMS	0.08386609	1.0380217235734286
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.0351554271865917
POTOCKI-LUPSKI SYNDROME	0.08334688400000001	1.0315954420213773
SCLEROSTEOSIS	0.08333330000000001	1.031427311051005
MUCKLE-WELLS SYNDROME	0.08333330000000001	1.031427311051005
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
ALKAPTONURIA	0.08333330000000001	1.031427311051005
DIPROSOPUS	0.08333330000000001	1.031427311051005
9P13 MICRODELETION SYNDROME	0.08317708	1.029493755383194
FRAXE INTELLECTUAL DISABILITY	0.08251991	1.0213598750976014
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08250585	1.0211858526120718
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507966
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.08228929	1.0185054607581405
GLASS SYNDROME	0.08226905400000001	1.018254997101158
PHENYLKETONURIA	0.08224078	1.0179050460516659
MEND SYNDROME	0.082207994	1.0174992493795059
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.0153791208136242
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.08155609	1.009430547074624
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08136754	1.0070968387071566
JACOBSEN SYNDROME	0.080513114	0.9965214947369542
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.079782904	0.9874835886801612
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.079676354	0.986164805192738
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.079094394	0.9789618090562686
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0790923	0.9789358913404295
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.078506794	0.9716890058914645
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07820027000000002	0.9678951176727982
ATKIN-FLAITZ SYNDROME	0.07820026999999999	0.9678951176727979
CLARK-BARAITSER SYNDROME	0.07820026999999999	0.9678951176727979
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.07778558000000001	0.9627624445202919
ATHYREOSIS	0.07767692400000001	0.9614175947914374
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	0.9520874151234571
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234571
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	0.9520874151234571
DDOST-CDG	0.07692310000000001	0.9520874151234571
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	0.9520874151234571
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234571
DIGEORGE SYNDROME; DGS	0.076464534	0.946411682897331
CONGENITAL ANALBUMINEMIA	0.07573640000000001	0.937399471767989
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07550772400000001	0.9345691185744649
THYROID HEMIAGENESIS	0.07550772400000001	0.9345691185744649
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07550772400000001	0.9345691185744649
THYROID ECTOPIA	0.07550772400000001	0.9345691185744649
FAMILIAL THYROID DYSHORMONOGENESIS	0.07550772400000001	0.9345691185744649
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.07550772400000001	0.9345691185744649
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.075212254	0.9309120471804813
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.07414335400000001	0.9176821300551256
CUSHING DISEASE	0.07411963	0.9173884949593428
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.914962997775895
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0739226	0.9149498285067198
SCHINZEL-GIEDION SYNDROME	0.07373067	0.9125742854307821
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.07373067	0.9125742854307821
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.073654754	0.9116346630259844
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.07362145399999999	0.9112225045076248
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.07320315399999999	0.9060451499061314
CRANIOPHARYNGIOMA	0.07286775399999999	0.9018938596040973
17P11.2 MICRODUPLICATION SYNDROME	0.072144994	0.8929481631857962
NORRIE DISEASE	0.07201613	0.8913531963596739
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.071978754	0.8908905886484969
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.07168092400000001	0.8872043072213804
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941577
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941577
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941577
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524647
SCHAAF-YANG SYNDROME; SHFYNG	0.071088904	0.8798767971301154
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.8750055290198838
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.070657664	0.8745392824316977
MICROPHTHALMIA, SYNDROMIC 1	0.07047855	0.8723223646882315
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471943
16Q24.3 MICRODELETION SYNDROME	0.07010212	0.8676632406321948
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.06978679400000001	0.8637604088916487
RABIES	0.06932783	0.8580797505667145
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875292
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.069206404	0.8565768448534923
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.06899329	0.8539391045987882
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06875619999999999	0.8510046102108654
FRONTONASAL DYSPLASIA 1; FND1	0.06871588	0.8505055642210679
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.06861319	0.8492345564658033
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.068188054	0.8439725917852855
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0679538	0.841073198945653
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067641964	0.8372135633981721
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064404
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726275
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726275
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726275
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726275
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726275
COFS SYNDROME	0.06701159	0.8294113407599653
DESANTO-SHINAWI SYNDROME	0.066998704	0.8292518490282064
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002706
9Q33.3Q34.11 MICRODELETION SYNDROME	0.06681480000000001	0.8269756448191864
HEPATOCELLULAR CARCINOMA	0.0666667	0.825142591468765
GLIOBLASTOMA	0.0666667	0.825142591468765
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0666667	0.825142591468765
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.066656754	0.8250194885070953
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.066411304	0.821981521289939
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.06584025399999999	0.8149135596710458
SMITH-LEMLI-OPITZ SYNDROME	0.065492644	0.8106111445789467
ALG11-CDG	0.065228294	0.8073392495540729
OROFACIODIGITAL SYNDROME TYPE 14	0.065107254	0.8058411214140662
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765598
CORNELIA DE LANGE SYNDROME	0.06489647	0.8032322198785146
MEIER-GORLIN SYNDROME 1; MGORS1	0.06468018	0.8005551698504079
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.7982359427281802
EMANUEL SYNDROME	0.064355364	0.7965348791206954
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394996
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119528
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06398344	0.7919315264245305
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.063873624	0.7905723192217631
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.790445156560573
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.06373695400000001	0.788880736497914
MUCOLIPIDOSIS TYPE IV	0.06363462	0.7876141350018842
6Q16 MICRODELETION SYNDROME	0.063624164	0.7874847197025457
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518367
KLEEFSTRA SYNDROME	0.06346701999999999	0.7855397275641351
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06313020999999999	0.7813709855050174
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605661
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443238
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057	0.7760532742188934
NANCE-HORAN SYNDROME	0.06259785000000001	0.774781895149648
HADDAD SYNDROME	0.0625	0.7735707927165708
DYSTONIA 12; DYT12	0.06247675	0.7732830243816803
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816803
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.06215023	0.7692416430178752
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701814
CENTRAL DIABETES INSIPIDUS	0.06203684999999999	0.7678383237142239
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411904
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.7655281318988553
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.061840374	0.7654065141931075
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.06172844	0.7640210922233165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.061656714	0.7631333300044624
COSTELLO SYNDROME; CSTLO	0.06148382399999999	0.7609934475348179
SUSAC SYNDROME	0.0610913	0.7561351259053736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.061088	0.7560942813675181
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.061014694	0.755186963279024
PERRY SYNDROME	0.06073392	0.7517117862269568
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	0.7515357834001979
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.06037726	0.747297358084072
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.060338294	0.7468150707319282
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.06033152399999999	0.746731277543661
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215693
VAN BOGAERT-HOZAY SYNDROME	0.06025901	0.7458337621442523
1Q21.1 MICRODELETION SYNDROME	0.060224774	0.7454100186297012
COFFIN-LOWRY SYNDROME	0.059956539999999996	0.7420900508214846
TURNPENNY-FRY SYNDROME; TPFS	0.059627124000000004	0.7380128252814283
SPINOCEREBELLAR ATAXIA 12	0.05937055	0.7348371748403009
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	0.7338996070395285
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.05905466	0.7309273623969211
RETT SYNDROME; RTT	0.05833875	0.7220664493375016
TRISOMY 9P	0.058150334	0.7197343995058137
16P13.11 MICRODELETION SYNDROME	0.057928254	0.7169856858794699
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.057910833999999994	0.7167700762281239
USHER SYNDROME TYPE 3	0.05787236	0.7162938784252603
AREDYLD SYNDROME	0.05760478	0.7129820052618187
DYSOSTOSIS, STANESCU TYPE	0.05760478	0.7129820052618187
TETRALOGY OF FALLOT	0.05760478	0.7129820052618187
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.05760478	0.7129820052618187
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	0.709573590463446
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325443999999996	0.7095246265265502
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267634
ALEXANDER DISEASE	0.05690614	0.7043348452838426
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.056905250000000004	0.7043238296357544
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363915
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.056680180000000004	0.7015381083826868
13Q12.3 MICRODELETION SYNDROME	0.0563492	0.6974415250071136
DOORS SYNDROME	0.056290494	0.6967149130557981
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.056217640000000006	0.6958131894312769
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.056101154	0.6943714267535107
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	0.6914071034758208
2Q23.1 MICRODUPLICATION SYNDROME	0.055750844	0.690035593403166
XP22.13P22.2 DUPLICATION SYNDROME	0.05574732999999999	0.6899921001589162
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	0.055555600000000004	0.6876190325095156
POSTERIOR URETHRAL VALVE	0.055555600000000004	0.6876190325095156
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.055555600000000004	0.6876190325095156
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.055555600000000004	0.6876190325095156
DEAFNESS-OLIGODONTIA SYNDROME	0.055555600000000004	0.6876190325095156
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.055555600000000004	0.6876190325095156
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095156
CLASSICAL EHLERS-DANLOS SYNDROME	0.055555600000000004	0.6876190325095156
NAGER SYNDROME	0.055555600000000004	0.6876190325095156
ANOPHTHALMIA PLUS SYNDROME	0.055555600000000004	0.6876190325095156
CLEFT LIP AND ALVEOLUS	0.055555600000000004	0.6876190325095156
3MC SYNDROME	0.055555600000000004	0.6876190325095156
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.055555600000000004	0.6876190325095156
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504074
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091228
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.055155454	0.6826663723747578
FILIPPI SYNDROME	0.055155454	0.6826663723747578
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.055155454	0.6826663723747578
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.055155454	0.6826663723747578
MIETENS SYNDROME	0.055155454	0.6826663723747578
COFFIN-SIRIS SYNDROME 8; CSS8	0.054903520000000004	0.6795481518292817
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0548395	0.6787557677948862
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05482505	0.6785769182276102
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.6785769182276102
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	0.6782767727600361
KNIEST-LIKE DYSPLASIA, LETHAL	0.05468078	0.6767912692953666
LETHAL KNIEST-LIKE DYSPLASIA	0.05468078	0.6767912692953666
N-ACETYLASPARTATE DEFICIENCY; NACED	0.054639154	0.6762760587702847
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307626
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307626
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307626
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307626
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.05441928	0.6735546490986405
15Q24 MICRODELETION SYNDROME	0.054010034	0.6684893570564631
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.053757679999999995	0.6653659381152599
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.05346055	0.661688320681022
CHAR SYNDROME	0.05323229399999999	0.6588631658832248
AICARDI SYNDROME	0.05312268999999999	0.6575065826325863
CEREBROFACIOARTICULAR SYNDROME	0.052802893999999996	0.653548425108945
COFFIN-SIRIS SYNDROME 1; CSS1	0.052716464	0.6524786695311131
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	0.6514282965430636
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	0.6514282965430636
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	0.6514282965430636
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0526316	0.6514282965430636
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	0.6514282965430636
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	0.6514282965430636
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	0.6514282965430636
1Q21.1 MICRODUPLICATION SYNDROME	0.052545084	0.6503574765318209
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05253729	0.6502610091596859
PARKINSON DISEASE, LATE-ONSET; PD	0.05249942	0.6497922871449631
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05242669	0.6488920982848947
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05242669	0.6488920982848947
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.051859294	0.6418693627088273
MONOSOMY 18P	0.051545233999999995	0.6379822004182583
GANGLIOCYTOMA	0.0514889	0.6372849470256678
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.051377123999999996	0.6359014806428409
RENPENNING SYNDROME 1; RENS1	0.05131497	0.6351321923380329
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.05114946	0.6330836531075925
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.050846470000000005	0.6293335056758295
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.050828894	0.6291159651917849
AMYOTROPHIC LATERAL SCLEROSIS	0.05072395	0.6278170593794512
HAMAMY SYNDROME; HMMS	0.05059527	0.6262243699457429
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	0.6262243699457429
KLEEFSTRA SYNDROME	0.050554054	0.6257142340450613
HISTIDINEMIA	0.05043863	0.624285615882205
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726196
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.050100484	0.620100337973822
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.05	0.6188566341732568
MENINGIOMA	0.049802	0.6164059619019305
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.049673023999999996	0.614809608836948
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.049576060000000005	0.6136094725434286
USHER SYNDROME TYPE 1	0.049408904000000003	0.6115405605525912
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04939145999999999	0.6113246538500607
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.049339454	0.6106809686877246
OCULOCEREBRORENAL SYNDROME OF LOWE	0.04909711	0.6076814448446829
MICROTRIPLICATION 11Q24.1	0.04898807	0.6063318422968779
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085961
MARSHALL SYNDROME	0.04865564	0.6022173120789135
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04860162	0.6015486993713527
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452713
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04817627000000001	0.5962840859844409
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.04806555	0.5949136898537276
YELLOW FEVER	0.048023750000000004	0.5943963257075587
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.048022553999999995	0.5943815226568693
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047619	0.5893866812539262
RING CHROMOSOME 1 SYNDROME	0.04752688000000001	0.5882464997911255
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.047414074	0.5868502849616345
PGM3-CDG	0.04740591999999999	0.5867493618217334
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.047222259999999995	0.5844761776330882
LISSENCEPHALY, X-LINKED, 2	0.04717029000000001	0.5838329380475288
PACHYDERMOPERIOSTOSIS	0.047011870000000004	0.5818721526878141
48,XXYY SYNDROME	0.046519614	0.5757794348615822
WOLFRAM SYNDROME	0.04619596	0.571773526360048
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.046073034	0.5702520549478004
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.04601637	0.5695507171014245
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.569348771804561
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.046000054	0.569348771804561
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.04590219399999999	0.5681375456001572
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.567705088584197
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.562596377560566
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.562596377560566
LITHIUM TRANSPORT	0.0454545	0.562596377560566
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.045261194000000005	0.5602038035500561
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.045197553999999994	0.5594161228260802
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.044757594	0.5539706795306629
CONGENITAL HYPOTHYROIDISM	0.044744634	0.5538102718910852
OGDEN SYNDROME; OGDNS	0.044734763999999996	0.5536881095914994
SLC39A8-CDG	0.04472331	0.5535463419137431
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.044594134	0.5519475134222238
LYME DISEASE	0.04454545	0.5513449450946619
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.04449460399999999	0.5507156174062384
YUNIS-VARON SYNDROME	0.044444410000000004	0.5500943596083246
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	0.5500943596083246
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.04422715	0.547405303761515
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054516
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.04414605	0.546401518300886
DISTAL TRISOMY 18Q	0.044023854	0.5448890821954974
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	0.5448890821954974
ABLEPHARON MACROSTOMIA SYNDROME	0.044023854	0.5448890821954974
TARP SYNDROME	0.044023854	0.5448890821954974
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044017060000000004	0.5448049919560459
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044011804	0.5447399377466615
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04385976	0.5428580689849367
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0438359	0.5425627505991093
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.043623973999999996	0.5399397143780331
LASSA FEVER	0.043478300000000004	0.5381366879515022
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	0.5381366879515022
HYDATIDIFORM MOLE	0.043478300000000004	0.5381366879515022
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	0.5381366879515022
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.043478300000000004	0.5381366879515022
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	0.5381366879515022
KEUTEL SYNDROME; KTLS	0.043478300000000004	0.5381366879515022
FRASER SYNDROME	0.043478300000000004	0.5381366879515022
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	0.5381366879515022
RINGED HAIR DISEASE	0.043478300000000004	0.5381366879515022
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	0.5381366879515022
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	0.5381366879515022
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	0.5381366879515022
OCULOTRICHOANAL SYNDROME	0.043478300000000004	0.5381366879515022
WERNER SYNDROME	0.043478300000000004	0.5381366879515022
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	0.5381366879515022
ASHERMAN SYNDROME	0.043478300000000004	0.5381366879515022
FAMILIAL THROMBOCYTOSIS	0.043478300000000004	0.5381366879515022
BRADDOCK SYNDROME	0.043478300000000004	0.5381366879515022
C SYNDROME	0.043478300000000004	0.5381366879515022
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	0.5381366879515022
JOHANSON-BLIZZARD SYNDROME	0.043478300000000004	0.5381366879515022
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	0.5381366879515022
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.043411370000000005	0.5373082864609978
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.04320984	0.534813922911299
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	0.534702528717148
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079054
OGDEN SYNDROME	0.043048633999999995	0.5328186548599284
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.043028354	0.5325676466091077
16P13.11 MICRODUPLICATION SYNDROME	0.042791624	0.529637607988951
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042697094	0.5284675976363831
8P INVERTED DUPLICATION/DELETION SYNDROME	0.04264144	0.5277787606940175
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0424828	0.5258152523651126
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.042435763999999994	0.525233081552213
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.042324794	0.5238595911383289
JAWAD SYNDROME	0.042321894	0.523823697453547
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.522827412535324
SHPRINTZEN OMPHALOCELE SYNDROME	0.04215154	0.521715203392388
HARTNUP DISEASE	0.042053813999999995	0.5205056357237636
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.041956473999999994	0.5193008456283551
4Q21 MICRODELETION SYNDROME	0.04195338	0.5192625507798324
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.04189021	0.518480687308218
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821367
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	0.5157142743821367
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
BARATELA-SCOTT SYNDROME	0.041365613999999995	0.5119876930110029
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.041279503999999995	0.5109218981156296
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04108196	0.5084768698168073
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.041075274	0.5083941163076856
INFANTILE MYOFIBROMATOSIS	0.0408333	0.5053991720037369
611426 TENTED EYEBROWS	0.0408333	0.5053991720037369
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264552
CORNELIA DE LANGE SYNDROME 1	0.040794010000000006	0.5049128744606035
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.040769613999999996	0.5046109219316576
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04072704	0.5040839778847919
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.04065564	0.5032002506111924
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040630700000000006	0.5028915649220669
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0406015	0.5025301526477096
WILSON DISEASE	0.0406015	0.5025301526477096
CHROMOSOME 10Q26 DELETION SYNDROME	0.040529263999999995	0.5016360780911868
ACROCEPHALOPOLYDACTYLY	0.04051068	0.5014060614573973
MAL DE MELEDA	0.04051068	0.5014060614573973
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.040308434000000004	0.49890283588069734
MUCOPOLYSACCHARIDOSIS, TYPE II	0.040104970000000004	0.49638453495638873
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.04006544	0.49589526690141134
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.4950853073386054
BUERGER DISEASE	0.04	0.4950853073386054
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04	0.4950853073386054
TYPHOID	0.04	0.4950853073386054
MERCURY POISONING	0.04	0.4950853073386054
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.039973369999999994	0.4947557042952446
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.039969264	0.4947048837884463
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561284
ZELLWEGER SYNDROME	0.03976288000000001	0.4921504416367022
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.03974961	0.49198619708599245
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	0.49138702009278595
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.49061716243987435
MEHMO SYNDROME	0.03962027	0.49038533874471313
MILD CANAVAN DISEASE	0.039504479999999995	0.4889521905512947
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.039325453999999996	0.48673636199550463
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0391926	0.4850920104099756
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.48465707796747864
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.03908618	0.48377483594980125
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	0.48377483594980125
GORLIN SYNDROME	0.03908618	0.48377483594980125
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03902825	0.48305782865344815
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.4823307958796213
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.4823307958796213
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03895455999999999	0.4821457577460035
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.038909554	0.48158871251245156
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.48076328153379116
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.038718393999999996	0.4792226998286803
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.038718393999999996	0.4792226998286803
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.038587064000000004	0.4775972109933609
2Q37 MICRODELETION SYNDROME	0.038476843999999996	0.47623300342898933
CYCLIC NEUTROPENIA	0.0384615	0.47604308870509426
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	0.47604308870509426
LIP, HAMARTOMATOUS	0.0384615	0.47604308870509426
LIP, MEDIAN NODULE OF UPPER	0.0384615	0.47604308870509426
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	0.47604308870509426
JUVENILE ABSENCE EPILEPSY	0.0384615	0.47604308870509426
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	0.47604308870509426
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	0.47604308870509426
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	0.47604308870509426
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	0.47604308870509426
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	0.47604308870509426
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	0.47604308870509426
BAZEX SYNDROME; BZX	0.0384615	0.47604308870509426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038429054000000004	0.47564150025804663
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.038402783999999995	0.4753163529824519
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.03811734	0.4717833747207529
248100 MACROSOMIA ADIPOSA CONGENITA	0.0380987	0.4715526649675331
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.47125561378312997
TETRASOMY 12P	0.03801637	0.4705336556337035
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.037994933999999994	0.4702683394175006
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037948784	0.4696971347441587
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0378835	0.46888910601405137
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0378835	0.46888910601405137
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.0378835	0.46888910601405137
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03776348	0.4674036025493819
BAKER-GORDON SYNDROME; BAGOS	0.037632554	0.4657831140756665
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03759781	0.46535308297771233
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.037582554	0.46516425744149326
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	0.46516425744149326
SILVER-RUSSELL SYNDROME; SRS	0.037582554	0.46516425744149326
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.037170654	0.460066116489174
HELSMOORTEL-VAN DER AA SYNDROME	0.037088734	0.45905218177974455
SMITH-MAGENIS SYNDROME	0.03707336	0.458861895741869
BRACHYDACTYLY, TYPE A1, D	0.037037	0.45841186319749816
DIABETIC EMBRYOPATHY	0.037037	0.45841186319749816
KAPOSIFORM LYMPHANGIOMATOSIS	0.037037	0.45841186319749816
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	0.45841186319749816
FIBROSCLEROSIS, MULTIFOCAL	0.037037	0.45841186319749816
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.037037	0.45841186319749816
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	0.45841186319749816
PROTEUS SYNDROME	0.037037	0.45841186319749816
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	0.45841186319749816
SYNPOLYDACTYLY 1	0.037037	0.45841186319749816
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	0.45841186319749816
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	0.45841186319749816
MALAKOPLAKIA	0.037037	0.45841186319749816
KIKUCHI-FUJIMOTO DISEASE	0.037037	0.45841186319749816
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	0.45841186319749816
BRACHYDACTYLY TYPE A4	0.037037	0.45841186319749816
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037037	0.45841186319749816
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	0.45841186319749816
CLEIDORHIZOMELIC SYNDROME	0.037037	0.45841186319749816
CARCINOMA OF ESOPHAGUS	0.037037	0.45841186319749816
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	0.45841186319749816
BRACHYDACTYLY, TYPE A4	0.037037	0.45841186319749816
CLEIDORHIZOMELIC SYNDROME	0.037037	0.45841186319749816
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	0.45841186319749816
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	0.45841186319749816
HYPOPARATHYROIDISM, X-LINKED	0.037037	0.45841186319749816
BRACHYDACTYLY, TYPE A3	0.037037	0.45841186319749816
HYPERPROLINEMIA, TYPE I	0.036996304	0.4579081634058119
HURLER-SCHEIE SYNDROME	0.03697476	0.4576415104592793
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.036841399999999996	0.45599089604461235
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.03680556	0.45554729960923707
PITUITARY APOPLEXY	0.03680355	0.45552242157254325
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0367747	0.45516534129462527
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.036724234	0.4545407169166215
WHITE-SUTTON SYNDROME; WHSUS	0.03662937399999999	0.4533666221102679
KEIPERT SYNDROME; KPTS	0.03653198	0.4521611636496946
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.036493694	0.4516872927477754
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774	0.44979458161781993
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.448793024041074
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	0.448793024041074
TRANSKETOLASE DEFICIENCY	0.036223533999999995	0.44834348658201045
DISTAL MONOSOMY 10Q	0.036149254	0.44742411316628267
THUMBS, CONGENITAL CLASPED	0.0361093	0.4469295972070475
LYNCH SYNDROME	0.03603924	0.44606245529124394
FAMILIAL COLORECTAL CANCER TYPE X	0.03603924	0.44606245529124394
COG1-CDG	0.035948139999999996	0.44493489850378026
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035945753999999996	0.44490536666519753
OCULOFACIOCARDIODENTAL SYNDROME	0.035844134	0.4436476024419039
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03579167	0.44299824855279846
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	0.44204062979707887
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.44204062979707887
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.4415910923380154
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664554	0.44142491695460717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.03561658	0.44083113639125066
RABSON-MENDENHALL SYNDROME	0.035598424	0.4406064171702496
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.43938301186728523
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.035459484	0.43888673835520897
CUSHING SYNDROME	0.035376540000000005	0.4378601294619118
17Q21.31 MICRODUPLICATION SYNDROME	0.035354123999999994	0.43758268365567904
MARTSOLF SYNDROME	0.03529858	0.4368952081979087
XQ28 (MECP2) DUPLICATION	0.035292634	0.4368216137669728
CHARGE SYNDROME	0.035279043999999996	0.43665340853380447
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.035242384	0.4361996628496287
MAN1B1-CDG	0.035221963999999994	0.4359469218002323
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03519641	0.43563063655163903
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.035034764	0.4336299225618877
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.035028354	0.43355058514138667
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.035028354	0.43355058514138667
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.035028354	0.43355058514138667
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035028354	0.43355058514138667
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035028354	0.43355058514138667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035028354	0.43355058514138667
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035007144000000004	0.4332880661571704
RODRIGUES BLINDNESS	0.03494004	0.4324575110455791
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.42977865395610065
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.034672514	0.4291463062473025
TYSHCHENKO SYNDROME	0.034659154	0.4289809477546513
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0344828	0.42679819089739157
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	0.42679819089739157
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0344828	0.42679819089739157
NASODIGITOACOUSTIC SYNDROME	0.0344828	0.42679819089739157
LATHOSTEROLOSIS	0.0344828	0.42679819089739157
DIAMOND-BLACKFAN ANEMIA 8	0.0344828	0.42679819089739157
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	0.42679819089739157
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	0.4261112600334591
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	0.4261112600334591
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03437055	0.42540885775367254
OCULODENTODIGITAL DYSPLASIA	0.034307279999999996	0.42462575656878965
22Q11.2 MICRODUPLICATION SYNDROME	0.034107394	0.4221517410252226
SAETHRE-CHOTZEN SYNDROME	0.033993579999999995	0.4207430500459867
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561085
CHOREOACANTHOCYTOSIS	0.03389067	0.4194693193215313
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440584	0.41389854518056124
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.4128770109116641
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.03329918	0.4121483691105885
WEILL-MARCHESANI SYNDROME 1; WMS1	0.03329918	0.4121483691105885
WEILL-MARCHESANI SYNDROME 2; WMS2	0.03329918	0.4121483691105885
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.41183052434327716
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033165534	0.41049421483597415
JOUBERT SYNDROME 1	0.033062694000000004	0.40922135051080666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.033062694	0.40922135051080655
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.40864143233605543
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.40601517806048176
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.032803653999999995	0.40601517806048176
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534614
ALSTRÖM SYNDROME	0.032706694	0.40481509127549303
CHERUBISM	0.03261998	0.403741820591979
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032547964	0.40285046900464655
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.032540483999999995	0.40275788805217416
ALLAN-HERNDON-DUDLEY SYNDROME	0.032453100000000006	0.40167632468976244
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.032431094	0.40140395350793
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.03242833	0.4013697431131929
COSTELLO SYNDROME	0.03236687	0.40060904453846713
SCHWARTZ-JAMPEL SYNDROME	0.03226168	0.39930709395149344
SECKEL SYNDROME	0.0322581	0.3992627838164866
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.3992627838164866
PRIMARY BILIARY CHOLANGITIS	0.0322581	0.3992627838164866
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	0.3992627838164866
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164866
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.3992627838164866
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.3992627838164866
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164866
DENT DISEASE	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164866
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164866
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164866
DEND SYNDROME	0.0322581	0.3992627838164866
DYSTONIA, JUVENILE-ONSET	0.0322581	0.3992627838164866
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.3992627838164866
SECKEL SYNDROME 2; SCKL2	0.0322581	0.3992627838164866
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164866
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164866
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.032173954	0.3982212976097037
WHIPPLE DISEASE	0.03209902	0.397293829549201
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0319766	0.39577862096609123
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.39547716352245266
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.031795554	0.39353779060228056
CHROMOSOME 18P DELETION SYNDROME	0.031795554	0.39353779060228056
RETT SYNDROME	0.03174403	0.3929000712178977
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.3911351416057663
CLASSIC PHENYLKETONURIA	0.031581224	0.3908849997542335
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.03157324	0.39078618072688875
FRAGILE X SYNDROME	0.03151734	0.39009429900988296
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.03138363	0.38843935259877693
NEPHRONOPHTHISIS 11; NPHP11	0.031263054	0.38694696744833534
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.03125	0.3867853963582854
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.03125	0.3867853963582854
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.03125	0.3867853963582854
MELNICK-NEEDLES SYNDROME	0.03125	0.3867853963582854
TOOTH MALFORMATION	0.03125	0.3867853963582854
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.03125	0.3867853963582854
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.03125	0.3867853963582854
GIGANTIFORM CEMENTOMA, FAMILIAL	0.03125	0.3867853963582854
MELNICK-NEEDLES SYNDROME	0.03125	0.3867853963582854
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03122452	0.3864700270175107
MONILETHRIX	0.03117284	0.38583037680042925
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.03116819	0.3857728231334511
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.03116819	0.3857728231334511
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.031110724	0.38506155882666315
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.3843827473617712
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.030974964	0.38338123929355594
HUNTINGTON DISEASE; HD	0.03076024	0.3807235718552316
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552316
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552316
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.030567954	0.3783436225200588
SHUKLA-VERNON SYNDROME; SHUVER	0.030540714000000004	0.3780064694257612
TEMPLE-BARAITSER SYNDROME	0.03045544	0.37695102181331136
20Q11.2 MICRODUPLICATION SYNDROME	0.030394924	0.3762020072518388
SIALURIA	0.030376904	0.37597897132088276
DUBOWITZ SYNDROME	0.03036438	0.37582396011115504
HARTNUP DISORDER	0.030137654000000003	0.37301774232636375
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02989154	0.3699715566931054
MENTAL RETARDATION, X-LINKED 21	0.02976955	0.36846167027704946
19P13.3 MICRODUPLICATION SYNDROME	0.029744824	0.3681556332943181
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.02967996	0.36735280295993783
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.029643810000000003	0.3669053696134306
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.029580774	0.3661251646775957
ATYPICAL TERATOID RHABDOID TUMOR	0.02943871	0.36436681970005186
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.36436681970005186
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.029365060000000002	0.36345524387791467
MONOSOMY 18Q	0.029305614	0.3627194728484134
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.029281164000000002	0.36241685195430273
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.029194190000000002	0.361340363216291
15Q11Q13 MICRODUPLICATION SYNDROME	0.029181284	0.36118062394187816
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.029116954	0.3603844029963509
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.029105564	0.3602434274550862
16P11.2P12.2 MICRODELETION SYNDROME	0.029103614	0.36021929204635345
HYPERCALCEMIA, INFANTILE, 1	0.0288333	0.3568735798021552
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.028799494000000002	0.356455158454658
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870538
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.028737334	0.3556857958870538
ADIPOSIS DOLOROSA	0.028665130000000004	0.354792117398777
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.028587844	0.35383553832220266
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.35363200875235573
DYSOSTEOSCLEROSIS	0.0285714	0.35363200875235573
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.35363200875235573
ACHONDROPLASIA	0.0285714	0.35363200875235573
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.35363200875235573
SCHEIE SYNDROME	0.0285714	0.35363200875235573
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.35363200875235573
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.35363200875235573
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.35363200875235573
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.028403360000000002	0.3515521553762263
LEIGH SYNDROME; LS	0.028398754	0.3514951463030862
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.35056191049875296
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.35056191049875296
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.34817072272710364
FRAGILE X MENTAL RETARDATION SYNDROME	0.02811972	0.3480415054618882
1Q41Q42 MICRODELETION SYNDROME	0.028116270000000002	0.3479988043541303
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.028104930000000004	0.3478584476694998
XQ25 MICRODUPLICATION SYNDROME	0.027832814000000004	0.344490431832206
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.3438095162547578
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.3438095162547578
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.3438095162547578
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.3438095162547578
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.3438095162547578
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.3438095162547578
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.3438095162547578
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.3438095162547578
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.3438095162547578
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.3438095162547578
OROFACIAL CLEFT 3	0.027777800000000002	0.3438095162547578
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.3438095162547578
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.3438095162547578
CLEFT CHIN	0.027777800000000002	0.3438095162547578
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.3438095162547578
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.3438095162547578
MENKES DISEASE	0.027777800000000002	0.3438095162547578
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.3438095162547578
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.3438095162547578
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.3438095162547578
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.3438095162547578
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.3438095162547578
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.3438095162547578
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.3438095162547578
DIMPLES, FACIAL	0.027777800000000002	0.3438095162547578
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.3438095162547578
DWARFISM, LEVI TYPE	0.027777800000000002	0.3438095162547578
NASAL BONES, ABSENCE OF	0.027777800000000002	0.3438095162547578
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.3438095162547578
ADAMS-OLIVER SYNDROME 2; AOS2	0.027521513999999997	0.3406374304278432
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.02746664	0.3399582476489708
COFFIN-SIRIS SYNDROME 2; CSS2	0.027408604	0.3392399283765532
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.3375584453929737
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.027269684000000002	0.33752049710416626
PROGRESSIVE SUPRANUCLEAR PALSY	0.02717174	0.3363082312206169
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206169
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.33566301129382786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.027098464	0.33540128444610334
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.027081624	0.33519285353171374
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.027051324	0.33481782641140484
OSTEOGENESIS IMPERFECTA, TYPE V	0.027006139999999998	0.33425857804823506
SALT-AND-PEPPER SYNDROME	0.026970064000000002	0.33381206060954643
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248825
HOLMES-GANG SYNDROME	0.026863334	0.3324910492382402
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.026861354	0.33246654251552693
BAND HETEROTOPIA; BH	0.026659834	0.32997230273715505
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.026583474	0.32902718488544563
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.02658292	0.329020327953939
PETTIGREW SYNDROME	0.026566984	0.32882308596749527
RICHARDS-RUNDLE SYNDROME; RRNS	0.026561493999999998	0.328755135509063
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.026524254	0.32829421108793083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.026424510000000002	0.3270596663655513
HURLER SYNDROME	0.026342504	0.326044667222711
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715318
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.3257141482715318
NIPAH VIRUS DISEASE	0.0263158	0.3257141482715318
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.3257141482715318
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.3257141482715318
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715318
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715318
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715318
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715318
HYPERLYSINEMIA, TYPE I	0.0263158	0.3257141482715318
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734314
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02617284	0.3239447133831036
HEART AND BRAIN MALFORMATION SYNDROME	0.026089454	0.3229126337971602
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.32109017527231604
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.02589962	0.3205630331913273
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.02572202	0.3183648544267439
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.025597234	0.316820361547705
LETTERER-SIWE DISEASE	0.02557931	0.3165985138214865
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.31618071133062353
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.025512194	0.31576781018430305
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02546448	0.31517724767544425
COFFIN-SIRIS SYNDROME 5	0.025359424	0.3138769556242501
SARCOSINEMIA	0.025335834	0.3135849790642472
AGEL AMYLOIDOSIS	0.02527774	0.31286594191813394
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.3111679725938201
PRIMARY HYPEROXALURIA TYPE 1	0.02504074	0.3099325614721527
KLEEFSTRA SYNDROME 2; KLEFS2	0.025031504	0.30981824627468824
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866284
ACATALASEMIA	0.025	0.3094283170866284
MYOPATHY AND DIABETES MELLITUS	0.025	0.3094283170866284
SCHIZOPHRENIA 4	0.025	0.3094283170866284
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866284
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866284
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866284
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.3088546369867497
CYSTINOSIS	0.024953649999999997	0.3088546369867497
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.3088546369867497
TOXIC EPIDERMAL NECROLYSIS	0.024953649999999997	0.3088546369867497
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02488188	0.30796633017405745
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.30796633017405745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.3069635843925739
TRISOMY 18P	0.02469528	0.30565675721532287
ALG13-CDG	0.02458615	0.3043060407255763
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02454545	0.30380229142535925
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02454545	0.30380229142535925
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.024456779999999997	0.3027048110703164
COFFIN-SIRIS SYNDROME 7; CSS7	0.024426503999999998	0.30233008100119185
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.024355704	0.3014537800072025
SULFOCYSTEINURIA	0.024355054	0.30144573487095827
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.30144573487095827
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.30144573487095827
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.30144573487095827
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.024255310000000002	0.3002111901485787
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.3002111901485787
OCULOSKELETODENTAL SYNDROME; OCSKD	0.024118794000000002	0.2985215135031628
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.024107484000000002	0.2983815281325128
RECOMBINANT 8 SYNDROME	0.024050324	0.29767405122832596
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02397014	0.296681603221235
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.02386231	0.29534697700397694
ENCEPHALITIS LETHARGICA	0.02384003	0.29507121448778934
DISTAL 16P11.2 MICRODELETION SYNDROME	0.023832544	0.29497855927252087
HYPOTONIA-CYSTINURIA SYNDROME	0.023824934	0.2948843692927997
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.2946933406269631
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.2946933406269631
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.2946933406269631
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02377625	0.29428180096523787
6Q TERMINAL DELETION SYNDROME	0.023750054	0.29395756959746183
RUBINSTEIN-TAYBI SYNDROME	0.023745314000000003	0.2938989019885423
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.023712344	0.2934908279239684
RECOMBINANT CHROMOSOME 8 SYNDROME	0.023646964	0.29268161098912343
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023553934000000002	0.2915301663355807
COFFIN-LOWRY SYNDROME; CLS	0.02353357	0.29127811840561457
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.023476593999999996	0.2905729188938414
MENTAL RETARDATION, X-LINKED 91; MRX91	0.023473464	0.29053417846854224
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.023452163999999998	0.2902705455423844
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0234458	0.29019177746998687
OCCIPITAL HORN SYNDROME	0.023428034	0.2899718853307324
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02341424	0.2898011551624967
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.02333679	0.2888425462361623
CORNELIA DE LANGE SYNDROME 3	0.023309974	0.2885106410461225
TEMPLE SYNDROME	0.02327938	0.28813197504880456
NEPHROGENIC DIABETES INSIPIDUS	0.023122953999999998	0.28619586969166083
NOONAN SYNDROME	0.023026329999999998	0.2849999416232537
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0230025	0.28470499455140674
CHROMOSOME 2Q37 DELETION SYNDROME	0.022902964	0.2834730242726254
CLEIDOCRANIAL DYSPLASIA	0.02288248	0.2832194910867373
HYPOCHONDROPLASIA	0.02288248	0.2832194910867373
MENTAL RETARDATION, X-LINKED 104; MRX104	0.022828794	0.2825550123414928
2Q31.1 MICRODELETION SYNDROME	0.022794964	0.28213629394281114
TAY-SACHS DISEASE; TSD	0.0227273	0.2812988076369171
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.2812988076369171
CAUDAL REGRESSION SEQUENCE	0.0227273	0.2812988076369171
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.2812988076369171
GAUCHER DISEASE, PERINATAL LETHAL	0.0227273	0.2812988076369171
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.2812988076369171
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.022676694	0.28067245046033773
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.2792026164456454
NEPHROSIALIDOSIS	0.02255794	0.2792026164456454
DISTAL MONOSOMY 15Q	0.022427854	0.27759252476338425
COFFIN-SIRIS SYNDROME	0.022300544	0.2760167920014523
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.02224623	0.27534454041688255
FONTAINE PROGEROID SYNDROME; FPS	0.022208870000000002	0.2748821307398283
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.022138034	0.2740053841690624
HENNEKAM-BEEMER SYNDROME	0.02211882	0.2737675699416823
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.27340281584150056
TRISOMY 20P	0.022088850000000004	0.27339662727515884
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691438
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691438
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691438
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021965954	0.27187552717689173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.021850404	0.2704453494953173
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021833164	0.27023196772785435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.2700956954970094
RIDDLE SYNDROME	0.021779494	0.2695676870167328
WILSON-TURNER SYNDROME	0.021779494	0.2695676870167328
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.021779494	0.2695676870167328
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.021779494	0.2695676870167328
PORPHYRIA	0.02173918	0.2690687152897316
QAZI-MARKOUIZOS SYNDROME	0.02169311	0.2684985007870044
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.02159248	0.26725298992506724
INFANT BOTULISM	0.021532080000000002	0.26650541111098597
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.02141875	0.26510271066396884
TRISOMY 17P	0.021411054000000002	0.26500745625083694
VASCULAR EHLERS-DANLOS SYNDROME	0.021378854	0.2646089125784293
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.021378854	0.2646089125784293
CHROMOSOME 16Q22 DELETION SYNDROME	0.021378854	0.2646089125784293
KAGAMI-OGATA SYNDROME	0.021378854	0.2646089125784293
EARLY MYOCLONIC ENCEPHALOPATHY	0.021378854	0.2646089125784293
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.021378854	0.2646089125784293
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.021378854	0.2646089125784293
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021378854	0.2646089125784293
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.021378854	0.2646089125784293
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.2641461315873946
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530143
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530143
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530143
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.2633433012530143
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530143
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.021243074	0.2629283455026684
XQ25 DUPLICATION SYNDROME	0.021121404	0.2614224197690712
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.26139259087930405
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.25934739347468827
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.25934739347468827
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.25907121013598944
FABRY DISEASE	0.02090412	0.2587330668710772
CRANDALL SYNDROME	0.0208333	0.2578565183344342
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.2578565183344342
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.2578565183344342
DERMOIDS OF CORNEA	0.0208333	0.2578565183344342
PUPIL, EGG-SHAPED	0.0208333	0.2578565183344342
POLYARTERITIS NODOSA	0.0208333	0.2578565183344342
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.2578565183344342
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.2578565183344342
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.2578565183344342
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.2578565183344342
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.2578565183344342
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.2578565183344342
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344342
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.2578565183344342
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.2578565183344342
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.2578565183344342
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0208333	0.2578565183344342
STICKLER SYNDROME, TYPE III	0.0208333	0.2578565183344342
IMINOGLYCINURIA	0.0208333	0.2578565183344342
UNIQUE GREEN PHENOMENON	0.0208333	0.2578565183344342
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.2578565183344342
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.2578565183344342
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344342
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.2578565183344342
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	0.2578565183344342
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.2578565183344342
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.2578565183344342
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.2578565183344342
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.2578565183344342
RIBOFLAVIN DEFICIENCY	0.0208333	0.2578565183344342
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.2578565183344342
GAUCHER DISEASE, TYPE I	0.0208333	0.2578565183344342
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.2578565183344342
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.2578565183344342
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.2578565183344342
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344342
TRANSALDOLASE DEFICIENCY	0.0208333	0.2578565183344342
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.2578565183344342
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.2578565183344342
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344342
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344342
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.2578565183344342
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.2578565183344342
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.2578565183344342
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0208333	0.2578565183344342
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344342
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.2578565183344342
CROUZON SYNDROME	0.0208333	0.2578565183344342
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0208333	0.2578565183344342
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344342
CLEFT LIP/PALATE	0.0208333	0.2578565183344342
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.0208333	0.2578565183344342
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.2578565183344342
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.2578565183344342
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.2578565183344342
GLYCINE ENCEPHALOPATHY	0.0208333	0.2578565183344342
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.2578565183344342
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.0208333	0.2578565183344342
DISTAL MONOSOMY 6P	0.020802894	0.2574801792380607
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02077497	0.2571345601850077
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.2542950479132978
NEPHRONOPHTHISIS 1	0.020408199999999998	0.2525949992306931
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.2525949992306931
NEPHRONOPHTHISIS 4	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.2525949992306931
OCHOA SYNDROME	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.2525949992306931
HELIX SYNDROME; HELIX	0.020408199999999998	0.2525949992306931
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.2525949992306931
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.2525949992306931
TERATOMA, PINEAL	0.020408199999999998	0.2525949992306931
FAMILIAL COLD URTICARIA	0.020408199999999998	0.2525949992306931
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306931
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.2525949992306931
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.2525949992306931
PANHYPOPHYSITIS	0.020408199999999998	0.2525949992306931
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.2525949992306931
PARATHYROID CARCINOMA	0.020408199999999998	0.2525949992306931
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.2525949992306931
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.2525949992306931
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.020258654	0.2507440485464117
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.020258654	0.2507440485464117
MENTAL RETARDATION, X-LINKED 98; MRX98	0.020258654	0.2507440485464117
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.020258654	0.2507440485464117
ISOLATED COMPLEX I DEFICIENCY	0.020258654	0.2507440485464117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.020258654	0.2507440485464117
COFFIN-SIRIS SYNDROME 6; CSS6	0.020208933999999998	0.25012865750938973
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.020198494000000004	0.24999944024417445
GORLIN-CHAUDHRY-MOSS SYNDROME	0.02012011	0.24902927107591366
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020060014	0.24828545491016818
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.020039670000000002	0.24803365452285578
SCARF SYNDROME	0.020039670000000002	0.24803365452285578
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.2475426536693027
DARIER DISEASE	0.02	0.2475426536693027
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	0.2475426536693027
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.2475426536693027
WERNER SYNDROME; WRN	0.02	0.2475426536693027
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	0.2475426536693027
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.2475426536693027
CATATRICHY	0.02	0.2475426536693027
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	0.2475426536693027
HAIR WHORL	0.02	0.2475426536693027
MIDPHALANGEAL HAIR	0.02	0.2475426536693027
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.2475426536693027
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.2475426536693027
HAIRY NOSE TIP	0.02	0.2475426536693027
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.2475426536693027
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.2475426536693027
JUVENILE HYALINE FIBROMATOSIS	0.02	0.2475426536693027
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.2475426536693027
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.2475426536693027
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.2475426536693027
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.2475426536693027
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.2475426536693027
NEVUS COMEDONICUS SYNDROME	0.02	0.2475426536693027
FAMILIAL MELANOMA	0.02	0.2475426536693027
TRICHODENTOOSSEOUS SYNDROME	0.02	0.2475426536693027
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.2475426536693027
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02	0.2475426536693027
KNOBLOCH SYNDROME	0.02	0.2475426536693027
DISSECTING CELLULITIS OF THE SCALP	0.02	0.2475426536693027
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.2475426536693027
RINGED HAIR	0.02	0.2475426536693027
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.2475426536693027
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.2475426536693027
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.2475426536693027
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01997806	0.24727109937822742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.019799544000000002	0.24506158316010604
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.019735464	0.24426845649774953
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.019656654000000003	0.24329301467096567
HADZISELIMOVIC SYNDROME	0.019656654000000003	0.24329301467096567
MEHMO SYNDROME; MEHMO	0.019570594	0.24222783863222666
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.019524734000000002	0.24166022332736295
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.01951446	0.24153306066617303
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.24028289600234692
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.24028289600234692
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01931055	0.23900923954068765
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.23876206820099888
CK SYNDROME	0.019242684	0.2381692530539916
SAGLIKER SYNDROME	0.01923343	0.23805471506813883
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697715
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.2380221632091813
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.2380221632091813
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0192308	0.2380221632091813
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.2380221632091813
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.2380221632091813
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.2380221632091813
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.2380221632091813
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.2380221632091813
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.2380221632091813
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.2380221632091813
ASPARTYLGLUCOSAMINURIA	0.019183310000000002	0.23743437317804358
MUENKE SYNDROME	0.019170314	0.23727351996168924
RIFT VALLEY FEVER	0.01903825	0.2356389463109801
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01897775	0.23489012978363047
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.2343887321386233
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.23353050175835183
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.23353050175835183
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.23353050175835183
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.23353050175835183
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.23353050175835183
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.23353050175835183
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.23353050175835183
MONOPHALANGY OF GREAT TOE	0.0188679	0.23353050175835183
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.23353050175835183
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.23353050175835183
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.23353050175835183
RAYNAUD DISEASE	0.0188679	0.23353050175835183
PUBIC BONE DYSPLASIA	0.0188679	0.23353050175835183
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.23353050175835183
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.23353050175835183
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.23353050175835183
CARPAL DISPLACEMENT	0.0188679	0.23353050175835183
HHHH SYNDROME	0.0188679	0.23353050175835183
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.23353050175835183
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.23353050175835183
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.23353050175835183
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.23353050175835183
TRACHEOBRONCHOMEGALY	0.0188679	0.23353050175835183
VAN DEN BOSCH SYNDROME	0.0188679	0.23353050175835183
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.23353050175835183
THROMBOCYTOPENIA 3	0.0188679	0.23353050175835183
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.23353050175835183
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.23353050175835183
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.23353050175835183
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.23353050175835183
VESICOURETERAL REFLUX 1	0.0188679	0.23353050175835183
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.23353050175835183
TOE, MISSHAPEN	0.0188679	0.23353050175835183
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.23353050175835183
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.23353050175835183
KNUCKLE PADS	0.0188679	0.23353050175835183
SPINAL ARACHNOIDITIS	0.0188679	0.23353050175835183
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.23353050175835183
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.23353050175835183
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.018840454	0.23319079897472142
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018804809999999998	0.23274962845735198
GAPO SYNDROME; GAPOS	0.01871829	0.23167875893757858
DUBOWITZ SYNDROME	0.01862476	0.2305211257176941
ALPHA-MANNOSIDOSIS	0.018571924	0.22986716753523054
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018563084	0.22975775368230872
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.018551924	0.22961962488156126
MAPLE SYRUP URINE DISEASE; MSUD	0.01854138	0.22948912039454675
RING CHROMOSOME 7 SYNDROME	0.018518510000000002	0.22920605537007596
WARBURG MICRO SYNDROME 2; WARBM2	0.018518510000000002	0.22920605537007596
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.018515294	0.2291662505113659
MYHRE SYNDROME	0.018408914	0.22784957113649884
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01840145	0.2277571882181495
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018368064	0.22734396526637932
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01817417	0.22494411350185156
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.018089454	0.22389557232943913
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.22389557232943913
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.018089454	0.22389557232943913
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.018089454	0.22389557232943913
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.22389557232943913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.22389557232943913
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.018089454	0.22389557232943913
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.22389557232943913
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018089454	0.22389557232943913
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.018089454	0.22389557232943913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018089454	0.22389557232943913
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.018042314	0.22331211429474054
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.018038044	0.22325926393818216
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.017957924	0.22226760806758294
MALAN OVERGROWTH SYNDROME	0.01790326	0.22159102448657397
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.017877484000000003	0.221271991514525
HALL-RIGGS SYNDROME	0.017859950000000003	0.22105497087005316
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.01777454	0.21999783996755834
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.21928207038447353
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.21928207038447353
BETA-THALASSEMIA MAJOR	0.01771259	0.2192310765978177
CRANIOFRONTONASAL SYNDROME; CFNS	0.017696144	0.21902752227370542
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.21741998028077694
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.21741998028077694
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.017566263999999998	0.21741998028077694
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0175439	0.21714317808544398
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544398
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544398
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544398
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544398
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544398
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.2167567640030662
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01749249	0.216506869694187
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.2161144403253251
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.2161144403253251
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01739359	0.21528277127179232
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.017370550000000002	0.21499760213476532
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094	0.2145340042529734
PITT-HOPKINS SYNDROME	0.01728192	0.21390061686502976
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017279324	0.21386848582858348
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.21339909544869579
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.21339909544869579
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.21339909544869579
CARDIAC ARRHYTHMIA	0.0172414	0.21339909544869579
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.21339909544869579
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.21339909544869579
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.21339909544869579
CERVICAL RIB	0.0172414	0.21339909544869579
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.21339909544869579
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.21339909544869579
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.21339909544869579
MYOPATHY, CONGENITAL	0.0172414	0.21339909544869579
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.21339909544869579
MOTION SICKNESS	0.0172414	0.21339909544869579
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.21339909544869579
PALMOMENTAL REFLEX	0.0172414	0.21339909544869579
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.21339909544869579
SICKLE CELL ANEMIA	0.0172414	0.21339909544869579
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.21339909544869579
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.21339909544869579
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.21339909544869579
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.21339909544869579
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.21339909544869579
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.21339909544869579
RHEUMATOID ARTHRITIS	0.0172414	0.21339909544869579
JUMPING FRENCHMAN OF MAINE	0.0172414	0.21339909544869579
269800 SENILE PLAQUE FORMATION	0.0172414	0.21339909544869579
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.21339909544869579
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.21339909544869579
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.21339909544869579
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.21339909544869579
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.21339909544869579
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.21339909544869579
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.21339909544869579
TRANSSEXUALITY	0.0172414	0.21339909544869579
ERYTHERMALGIA, PRIMARY	0.0172414	0.21339909544869579
MOSAIC TRISOMY 15	0.0172414	0.21339909544869579
DIASTEMATOMYELIA	0.0172414	0.21339909544869579
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.21339909544869579
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.21339909544869579
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.21339909544869579
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.21339909544869579
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.017207554	0.2129801790158912
CRANIOFRONTONASAL DYSPLASIA	0.01715059	0.21227512802971027
HEART-HAND SYNDROME TYPE 2	0.01715059	0.21227512802971027
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.017102	0.2116737231526207
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01708913	0.21151442945498453
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01708913	0.21151442945498453
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.017078864000000003	0.21138736581085613
CARDIOFACIOCUTANEOUS SYNDROME	0.017056274	0.2111077663835366
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.017056104	0.21110566227098038
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01703874	0.21089074573906472
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.017027694	0.21075402793144316
WIEACKER-WOLFF SYNDROME	0.017000453999999998	0.21041687483714555
BILATERAL POLYMICROGYRIA	0.017000453999999998	0.21041687483714555
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026911
HYPOPHOSPHATASIA	0.01693283	0.20957988361655894
SOTOS SYNDROME	0.016899634	0.2091690123199986
GABRIELE-DE VRIES SYNDROME; GADEVS	0.016887594	0.2090199916424897
CHROMOSOME 19P13.13 DELETION SYNDROME	0.016799254	0.20792659574123237
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.016714094	0.2068725591219085
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.2067934197355304
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.01669385	0.20662199644786444
ACROOSTEOLYSIS DOMINANT TYPE	0.01669385	0.20662199644786444
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.01666666	0.206285462210201
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.016642334	0.20598437608054304
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185232
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.016585854	0.20528531562658092
NIJMEGEN BREAKAGE SYNDROME	0.01657558	0.205158152965391
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.016553654	0.20488677195417337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.016510550000000002	0.20435326802698528
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062444
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0164549	0.20366448059315045
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0164549	0.20366448059315045
GENITOPATELLAR SYNDROME; GTPTS	0.016437603999999998	0.2034504057062572
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.016410413999999998	0.20311387146859378
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.016376670000000003	0.20269621750332298
AMISH LETHAL MICROCEPHALY	0.01628802	0.2015989846909338
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0162537	0.20117420149723722
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.19963077305160914
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01612699	0.1996058950149154
SILVER-RUSSELL SYNDROME	0.01612699	0.1996058950149154
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01612699	0.1996058950149154
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.01609678	0.19923198183654794
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01585044	0.19618299897130312
LEPRECHAUNISM	0.015738620000000002	0.19479898799463805
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.015727404	0.1946601660744603
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01572366	0.19461382608969338
COHEN SYNDROME	0.015705234000000002	0.1943857650428679
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.015686343999999998	0.19415196100647716
MONOSOMY 9P	0.015646964	0.19366454952140233
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01563998	0.19357810762674105
ACROMICRIC DYSPLASIA	0.01560474	0.19314193747097574
MENTAL RETARDATION, X-LINKED 9	0.015587804	0.19293231835184854
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.01554339	0.19238260038084515
FRIED SYNDROME	0.015529873999999999	0.1922153110554954
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01551929	0.19208431148317362
CHIME SYNDROME	0.01544561	0.19117236434705592
TRISOMY X	0.015380584	0.1903675289171809
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.015346694000000001	0.18994806789053828
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.189361391801342
TENORIO SYNDROME; TNORS	0.015235409999999998	0.1885706910569915
2P15P16.1 MICRODELETION SYNDROME	0.015221484	0.1883983271072416
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.015190224	0.18801141793955647
X SMALL RINGS	0.015176894	0.1878464307608859
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.015159680000000002	0.18763337079887277
DYSTONIA 28, CHILDHOOD-ONSET	0.015110123999999999	0.18702000961161092
BRANCHIOOCULOFACIAL SYNDROME	0.01510141	0.1869121552774072
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014903434	0.18446178005726552
PROPIONIC ACIDEMIA	0.014903434	0.18446178005726552
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.014903434	0.18446178005726552
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.014903434	0.18446178005726552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014903434	0.18446178005726552
NIEMANN-PICK DISEASE, TYPE A	0.014903434	0.18446178005726552
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014890644000000001	0.18430347653024404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.014831254	0.18356839862017302
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.014831254	0.18356839862017302
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.014831254	0.18356839862017302
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017302
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017302
PROLIDASE DEFICIENCY	0.01480114	0.18319567364654316
LANDAU-KLEFFNER SYNDROME	0.014781964000000002	0.182958329750205
19P13.12 MICRODELETION SYNDROME	0.014630054	0.1810781195242598
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.014630054	0.1810781195242598
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.014630054	0.1810781195242598
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.014564569999999999	0.18026761536761576
GLYCEROL KINASE DEFICIENCY; GKD	0.014544894	0.1800240829049359
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.014544894	0.1800240829049359
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.014544894	0.1800240829049359
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01451115	0.1796064289396651
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.014504474	0.17952379920187028
GOLDBERG-SHPRINTZEN SYNDROME	0.014504474	0.17952379920187028
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014504474	0.17952379920187028
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.17950981304193797
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492348
LEGIONELLOSIS	0.0144928	0.17937930855492348
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492348
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492348
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	0.17937930855492348
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.014484130000000001	0.17927199881455788
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.014484130000000001	0.17927199881455788
KAPUR-TORIELLO SYNDROME	0.014484130000000001	0.17927199881455788
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.014484130000000001	0.17927199881455788
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.014450029999999999	0.1788499385900517
LEGIUS SYNDROME	0.014393050000000001	0.17814468956974785
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.17685226937494042
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.17681600437617787
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0142857	0.17681600437617787
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.17681600437617787
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.17681600437617787
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0142857	0.17681600437617787
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.17681600437617787
TEMTAMY SYNDROME	0.014128304	0.1748678932003312
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01411882	0.1747505084739612
2Q24 MICRODELETION SYNDROME	0.01411882	0.1747505084739612
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.01409776	0.17448984605964743
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.1743257252802647
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.1743257252802647
HARLEQUIN ICHTHYOSIS	0.0140845	0.1743257252802647
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.1743257252802647
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.1743257252802647
17Q12 MICRODUPLICATION SYNDROME	0.0140845	0.1743257252802647
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.1743257252802647
FRANK-TER HAAR SYNDROME	0.01398611	0.17310793919553855
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01398611	0.17310793919553855
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.01395892	0.17277140495787513
SOTOS SYNDROME 2	0.013935119999999999	0.17247682920000865
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310083
ALAZAMI SYNDROME; ALAZS	0.013875024	0.17173301303426314
BOHRING-OPITZ SYNDROME	0.013825854	0.17112442942021716
BOHRING-OPITZ SYNDROME	0.013825854	0.17112442942021716
15Q14 MICRODELETION SYNDROME	0.013760643999999999	0.17031731659792837
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013705834	0.16963892595554766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.013688254	0.16942133596297235
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013603144000000001	0.16836791820028263
MACS SYNDROME	0.013582750000000001	0.16811549895633604
CARPENTER-WAZIRI SYNDROME	0.013582750000000001	0.16811549895633604
FOUNTAIN SYNDROME	0.013582750000000001	0.16811549895633604
TRISOMY 13	0.013580249999999999	0.16808455612462736
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.013555560000000001	0.16777896471867265
ACROMICRIC DYSPLASIA	0.013555560000000001	0.16777896471867265
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01355446	0.16776534987272082
HERMANSKY-PUDLAK SYNDROME	0.01355446	0.16776534987272082
X-LINKED RECESSIVE OCULAR ALBINISM	0.01355446	0.16776534987272082
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.01355446	0.16776534987272082
RETINAL CONE DYSTROPHY 3B	0.01355446	0.16776534987272082
OCULOCUTANEOUS ALBINISM	0.01355446	0.16776534987272082
OCULAR ALBINISM	0.01355446	0.16776534987272082
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01355446	0.16776534987272082
CONE-ROD DYSTROPHY, X-LINKED, 3	0.01355446	0.16776534987272082
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.013508524000000001	0.1671967939057732
PERIPHERAL HYPOTHYROIDISM	0.013494704	0.16702574193208766
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.013494704	0.16702574193208766
PRIMARY CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208766
PERMANENT CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208766
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.013494704	0.16702574193208766
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.013429804	0.1662224660209308
EPIDERMAL NEVUS SYNDROME	0.013244604	0.16393022104795305
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.013244604	0.16393022104795305
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.013215089999999999	0.16356492235393325
CONO-SPONDYLAR DYSPLASIA	0.01314663	0.16271758385042323
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.013143364000000001	0.16267716013507905
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.013143364000000001	0.16267716013507905
MOEBIUS SYNDROME	0.013140009999999999	0.16263564723205867
STICKLER SYNDROME	0.01305759	0.1616155239562875
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.013052284	0.16154985089026905
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026905
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.013052284	0.16154985089026905
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.013024053999999998	0.1612004444346148
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.013024053999999998	0.1612004444346148
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.013024053999999998	0.1612004444346148
GAUCHER DISEASE, TYPE II	0.013024053999999998	0.1612004444346148
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.013024053999999998	0.1612004444346148
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.013024053999999998	0.1612004444346148
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.013024053999999998	0.1612004444346148
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.013007694	0.16099795454391333
JOUBERT SYNDROME 10	0.012997494000000002	0.160871707790542
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.012990159999999999	0.16078093389944142
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01294915	0.16027334768809254
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.012904033999999998	0.15971494096994532
HYPOPHOSPHATASIA, INFANTILE	0.01288425	0.15947007177693565
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.01282051	0.1586811533396916
CAFFEY DISEASE	0.01282051	0.1586811533396916
MENKES DISEASE	0.01282051	0.1586811533396916
SCLERODERMA	0.01282051	0.1586811533396916
FAMILIAL DYSAUTONOMIA	0.01282051	0.1586811533396916
2Q33.1 DELETION SYNDROME	0.01282051	0.1586811533396916
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012812524	0.15858230955808145
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.012812524	0.15858230955808145
CORNEODERMATOOSSEOUS SYNDROME	0.01276747	0.1580246702221606
MARFAN SYNDROME	0.012710860000000001	0.15732400074094965
NOONAN SYNDROME 5; NS5	0.012638954	0.1564340106382124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012638954	0.1564340106382124
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.1558745642409198
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.1558745642409198
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.1558745642409198
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.01257065	0.15558860296740099
SIFRIM-HITZ-WEISS SYNDROME	0.01254258	0.15524117685297611
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.012531274	0.15510124099085687
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.1547974566462739
CYCLIC VOMITING SYNDROME	0.01250673	0.1547974566462739
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01250673	0.1547974566462739
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.1547974566462739
TUBEROUS SCLEROSIS-1	0.01250673	0.1547974566462739
HURLER SYNDROME	0.012482484	0.1544973606872306
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.012482484	0.1544973606872306
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012482484	0.1544973606872306
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.012478499999999998	0.15444805019061966
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.01246214	0.1542455602999182
SCARF SYNDROME	0.01246214	0.1542455602999182
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.01246214	0.1542455602999182
MILROY DISEASE	0.012461970000000001	0.15424345618736202
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.012451940000000002	0.15411931354654687
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.012451940000000002	0.15411931354654687
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.012380203999999999	0.15323142755636576
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01229416	0.1521664495517497
MOEBIUS SYNDROME; MBS	0.0122706	0.15187484430572726
20Q13.33 MICRODELETION SYNDROME	0.01226697	0.1518299153140863
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.012235593999999999	0.15144157039900988
FLOATING-HARBOR SYNDROME	0.012198874	0.15098708208687306
3P25.3 MICRODELETION SYNDROME	0.01217589	0.1507026060692763
STURGE-WEBER SYNDROME	0.01217589	0.1507026060692763
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01214675	0.15034193642288013
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0120934	0.14968161639421726
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0120934	0.14968161639421726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0120934	0.14968161639421726
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.012079124	0.1495049204480281
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01204918	0.14913429958695443
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692465
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692465
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692465
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692465
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692465
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692465
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692465
CLASSIC HOMOCYSTINURIA	0.012048200000000002	0.14912216999692465
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692465
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692465
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692465
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.011960354	0.14803488839921294
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.011960354	0.14803488839921294
KID SYNDROME	0.01195286	0.14794213416688304
ATKIN-FLAITZ SYNDROME	0.01193693	0.14774496644323545
SCHEIE SYNDROME	0.01193693	0.14774496644323545
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.01193693	0.14774496644323545
VICI SYNDROME	0.011840514	0.1465516128184265
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.011840514	0.1465516128184265
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.011840514	0.1465516128184265
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01178159	0.145822302652186
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.145822302652186
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0117284	0.14516396296475248
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.011690820000000001	0.1446988303185079
ALAZAMI-YUAN SYNDROME	0.011656654	0.1442759532032446
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.011656654	0.1442759532032446
MACDERMOT-WINTER SYNDROME	0.011656654	0.1442759532032446
TREACHER-COLLINS SYNDROME	0.011656654	0.1442759532032446
CRANIOSYNOSTOSIS 6; CRS6	0.011656654	0.1442759532032446
LIG4 SYNDROME	0.011656654	0.1442759532032446
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.011656654	0.1442759532032446
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.011656654	0.1442759532032446
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011656654	0.1442759532032446
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.14403912914647915
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011603744	0.14362107911296243
BARDET-BIEDL SYNDROME 1; BBS1	0.011603744	0.14362107911296243
SIALIDOSIS TYPE 1	0.01153357	0.14275252620403295
ASPARTYLGLUCOSAMINURIA; AGU	0.01153357	0.14275252620403295
ZIMMERMANN-LABAND SYNDROME 1	0.01153357	0.14275252620403295
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01153357	0.14275252620403295
MOSAIC TRISOMY 1	0.01153357	0.14275252620403295
FOUNTAIN SYNDROME	0.01153357	0.14275252620403295
MUCOPOLYSACCHARIDOSIS TYPE 6	0.01153357	0.14275252620403295
DUANE RETRACTION SYNDROME	0.011523304	0.14262546255990452
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.011486684	0.14217221196103602
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.011486534	0.1421703553911335
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.011481974	0.1421139156660969
WIEDEMANN-STEINER SYNDROME; WDSTS	0.011457734	0.14181389396984972
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.01145599	0.14179230825044972
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01145599	0.14179230825044972
BOWEN-CONRADI SYNDROME	0.01145599	0.14179230825044972
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.14068670849636655
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.011305544	0.13993021814675316
AICARDI-GOUTIERES SYNDROME 5	0.011305544	0.13993021814675316
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.011305544	0.13993021814675316
FOLATE MALABSORPTION, HEREDITARY	0.011305544	0.13993021814675316
ARGININOSUCCINIC ACIDURIA	0.011305544	0.13993021814675316
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.011305544	0.13993021814675316
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.011263844	0.13941409171385263
ALSTROM SYNDROME; ALMS	0.011263844	0.13941409171385263
BEHÇET DISEASE	0.01125686	0.13932764981919135
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683453
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01113831	0.13786034073956654
EAR-PATELLA-SHORT STATURE SYNDROME	0.011118114	0.1376103721678913
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0111111	0.13752355895924948
TRISOMY 4P	0.0111111	0.13752355895924948
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0111111	0.13752355895924948
CHROMOSOME 18Q DELETION SYNDROME	0.0111111	0.13752355895924948
TEEBI-SHALTOUT SYNDROME; TBSH	0.0111111	0.13752355895924948
WARBURG MICRO SYNDROME 3; WARBM3	0.0111111	0.13752355895924948
UNILATERAL POLYMICROGYRIA	0.01109745	0.13735461109812014
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	0.13735461109812014
GOLDENHAR SYNDROME	0.01109083	0.1372726744797556
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.011058189999999999	0.1368686848689673
LOWRY-WOOD SYNDROME	0.011058189999999999	0.1368686848689673
LAMB-SHAFFER SYNDROME	0.011027224	0.13648541457829114
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010998094	0.13612486870322177
PELVISCAPULAR DYSPLASIA	0.01097775	0.13587306831590937
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.01097775	0.13587306831590937
EMERY-NELSON SYNDROME	0.01097775	0.13587306831590937
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01097775	0.13587306831590937
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.010947004	0.13549252099442355
LOCKED-IN SYNDROME	0.01094113	0.13541981771704087
FRYNS SYNDROME	0.01094098	0.13541796114713836
MUCOLIPIDOSIS TYPE II	0.01094098	0.13541796114713836
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.13435196821764223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.13435196821764223
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.13435196821764223
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.13435196821764223
VICI SYNDROME; VICIS	0.010854853999999999	0.13435196821764223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.13435196821764223
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.13435196821764223
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.13435196821764223
HYDROXYKYNURENINURIA	0.010854853999999999	0.13435196821764223
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.13435196821764223
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.13435196821764223
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.13435196821764223
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.13435196821764223
MARINESCO-SJOGREN SYNDROME; MSS	0.010854853999999999	0.13435196821764223
ARIMA SYNDROME	0.010854853999999999	0.13435196821764223
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010854853999999999	0.13435196821764223
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.13435196821764223
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.13435196821764223
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.13435196821764223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.13435196821764223
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.13435196821764223
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010854853999999999	0.13435196821764223
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010854853999999999	0.13435196821764223
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.010854853999999999	0.13435196821764223
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.13435196821764223
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.13435196821764223
C SYNDROME	0.010854853999999999	0.13435196821764223
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.010854853999999999	0.13435196821764223
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.13435196821764223
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.13435196821764223
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.13435196821764223
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.13435196821764223
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.13435196821764223
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.13435196821764223
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.13435196821764223
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.13435196821764223
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.13435196821764223
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010854853999999999	0.13435196821764223
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.010854853999999999	0.13435196821764223
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.13435196821764223
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.13435196821764223
REVESZ SYNDROME	0.010854853999999999	0.13435196821764223
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.13435196821764223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.010854853999999999	0.13435196821764223
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.010854853999999999	0.13435196821764223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.010840454	0.13417373750700035
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01077995	0.13342487147111998
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01077995	0.13342487147111998
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01077995	0.13342487147111998
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.01077995	0.13342487147111998
KABUKI SYNDROME 1	0.010766974	0.13326426579741935
XERODERMA PIGMENTOSUM	0.01071829	0.1326616974698575
ELSAHY-WATERS SYNDROME; ESWS	0.010594734	0.1311324284640193
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.010594734	0.1311324284640193
LEUKOCYTE ADHESION DEFICIENCY	0.01057582	0.13089832737644422
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.01057256	0.13085797792389614
MEIER-GORLIN SYNDROME 6; MGORS6	0.01057256	0.13085797792389614
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.01057256	0.13085797792389614
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.01045254	0.12937247445922664
CHITAYAT SYNDROME	0.01045254	0.12937247445922664
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.010408434	0.12882656864508973
JABERI-ELAHI SYNDROME; JABELS	0.010408434	0.12882656864508973
HOLOPROSENCEPHALY	0.010333354	0.12789729352321516
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010319494	0.12772574646422236
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.1275995739736471
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	0.1275995739736471
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.1275995739736471
PIERSON SYNDROME	0.010309299999999999	0.1275995739736471
FUCOSIDOSIS	0.010251963999999999	0.12688991869410793
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.010228414	0.12659843721941233
STÜVE-WIEDEMANN SYNDROME	0.01022142	0.1265118715534242
FREEMAN-SHELDON SYNDROME	0.01022142	0.1265118715534242
MEIER-GORLIN SYNDROME 3; MGORS3	0.0101692	0.12586553768469366
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010122164	0.12528336687179417
PIERPONT SYNDROME	0.010122164	0.12528336687179417
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.010058614	0.12449680008975997
DOWN SYNDROME	0.01004918	0.12438003422002414
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009961134	0.12329027719577579
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009961134	0.12329027719577579
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009961134	0.12329027719577579
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984134
IRIDOGONIODYSGENESIS, TYPE 2	0.00986288	0.1220741744010946
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00986288	0.1220741744010946
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.009791154	0.12118641218224037
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.009787800000000001	0.12114489927922006
17Q12 MICRODELETION SYNDROME	0.009757004	0.12076373310110004
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00970641	0.1201375244501128
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009636984	0.11927822963643056
COWDEN SYNDROME	0.009636984	0.11927822963643056
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009636984	0.11927822963643056
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009634684000000001	0.1192497622312586
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009634684000000001	0.1192497622312586
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00957661	0.11853097262779903
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00957661	0.11853097262779903
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00957661	0.11853097262779903
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00957661	0.11853097262779903
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.11825810636065935
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009554564	0.11825810636065935
FANCONI ANEMIA	0.009554564	0.11825810636065935
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.009554564	0.11825810636065935
OKAMOTO SYNDROME	0.009554564	0.11825810636065935
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.009554564	0.11825810636065935
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.009554564	0.11825810636065935
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009554564	0.11825810636065935
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009554564	0.11825810636065935
RAHMAN SYNDROME	0.009554564	0.11825810636065935
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009554564	0.11825810636065935
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009554564	0.11825810636065935
OCULOECTODERMAL SYNDROME; OES	0.009554564	0.11825810636065935
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009543604	0.11812245298644859
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.009474124	0.11726248980760143
FETAL HYDANTOIN SYNDROME	0.009474124	0.11726248980760143
LATERAL MENINGOCELE SYNDROME	0.009474124	0.11726248980760143
WOLF-HIRSCHHORN SYNDROME	0.009474124	0.11726248980760143
RITSCHER-SCHINZEL SYNDROME 1	0.009474124	0.11726248980760143
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009474124	0.11726248980760143
DISTAL TRISOMY 17Q	0.009474124	0.11726248980760143
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009474124	0.11726248980760143
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009456589999999999	0.11704546916312955
AICARDI-GOUTIERES SYNDROME 7	0.009426164	0.11666888252410246
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.009426164	0.11666888252410246
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.009426164	0.11666888252410246
KRABBE DISEASE	0.009426164	0.11666888252410246
COG4-CDG	0.009426164	0.11666888252410246
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009426164	0.11666888252410246
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.009426164	0.11666888252410246
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.009426164	0.11666888252410246
INFANTILE DYSTONIA-PARKINSONISM	0.009426164	0.11666888252410246
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009426164	0.11666888252410246
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.009426164	0.11666888252410246
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.009426164	0.11666888252410246
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009426164	0.11666888252410246
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00941558	0.11653788295178064
LARYNGOTRACHEAL ANGIOMA	0.00941558	0.11653788295178064
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704422
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704422
PLAGUE	0.00937055	0.11598054066704422
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704422
CUTANEOUS MASTOCYTOSIS	0.00937055	0.11598054066704422
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.11598054066704422
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704422
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704422
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00937055	0.11598054066704422
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704422
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704422
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.11532373574406347
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406347
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406347
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.11532373574406347
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.11532373574406347
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406347
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406347
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406347
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406347
WEAVER SYNDROME	0.009317484000000001	0.11532373574406347
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.11532373574406347
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009317484000000001	0.11532373574406347
MENTAL RETARDATION, X-LINKED 90	0.009317484000000001	0.11532373574406347
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.11532373574406347
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406347
ARGININEMIA	0.009317484000000001	0.11532373574406347
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0092456	0.11443401793824524
SPINOCEREBELLAR ATAXIA TYPE 27	0.009183779999999999	0.11366886359575341
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575341
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00908913	0.11249736798726345
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.00908913	0.11249736798726345
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00908913	0.11249736798726345
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.11150571211666423
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.11150571211666423
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.11150571211666423
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00900901	0.11150571211666423
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.11150571211666423
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00900901	0.11150571211666423
EDICT SYNDROME	0.00900901	0.11150571211666423
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00900901	0.11150571211666423
NEUROTROPHIC KERATOPATHY	0.00900901	0.11150571211666423
ALAND ISLAND EYE DISEASE	0.00900901	0.11150571211666423
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00900901	0.11150571211666423
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.11150571211666423
MEGALOCORNEA	0.00900901	0.11150571211666423
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00900901	0.11150571211666423
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00900901	0.11150571211666423
SANJAD-SAKATI SYNDROME	0.00900901	0.11150571211666423
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00900901	0.11150571211666423
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.11150571211666423
ÅLAND ISLANDS EYE DISEASE	0.00900901	0.11150571211666423
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.00900901	0.11150571211666423
BABESIOSIS	0.00898989	0.11126906133975638
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.008974934	0.11108394894334248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.008974934	0.11108394894334248
11P15.4 MICRODUPLICATION SYNDROME	0.008974934	0.11108394894334248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008974934	0.11108394894334248
THAUVIN-ROBINET-FAIVRE SYNDROME	0.008948914	0.1107618959509187
8P23.1 DUPLICATION SYNDROME	0.008948914	0.1107618959509187
TEMPLE-BARAITSER SYNDROME; TMBTS	0.008948914	0.1107618959509187
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.008948914	0.1107618959509187
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.008948914	0.1107618959509187
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.008948914	0.1107618959509187
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.008948914	0.1107618959509187
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.008948914	0.1107618959509187
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.008948914	0.1107618959509187
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00892857	0.1105100955636063
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00892857	0.1105100955636063
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.1105100955636063
SPONDYLO-OCULAR SYNDROME	0.00892857	0.1105100955636063
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.1105100955636063
PTERYGIUM COLLI, ISOLATED	0.00892857	0.1105100955636063
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00892857	0.1105100955636063
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.1105100955636063
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.1105100955636063
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.1105100955636063
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00892857	0.1105100955636063
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.1105100955636063
THORACOMELIC DYSPLASIA	0.00892857	0.1105100955636063
JUNG SYNDROME	0.00892857	0.1105100955636063
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00892857	0.1105100955636063
ISOLATED KLIPPEL-FEIL SYNDROME	0.00892857	0.1105100955636063
FLOATING-HARBOR SYNDROME	0.00892857	0.1105100955636063
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00892857	0.1105100955636063
WILDERVANCK SYNDROME	0.00892857	0.1105100955636063
CEREBROFACIOTHORACIC DYSPLASIA	0.00892857	0.1105100955636063
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.1105100955636063
RING CHROMOSOME 6 SYNDROME	0.00892857	0.1105100955636063
RING CHROMOSOME 8 SYNDROME	0.00892857	0.1105100955636063
SPONDYLOOCULAR SYNDROME; SOS	0.00892857	0.1105100955636063
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.1105100955636063
EDINBURGH MALFORMATION SYNDROME	0.00892857	0.1105100955636063
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00892857	0.1105100955636063
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.1105100955636063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.008887593999999999	0.1100029301747686
ZTTK SYNDROME; ZTTKS	0.008887593999999999	0.1100029301747686
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00888061	0.1099164882801073
5Q14.3 MICRODELETION SYNDROME	0.00888061	0.1099164882801073
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00888061	0.1099164882801073
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00888061	0.1099164882801073
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.10857134150006832
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.10857134150006832
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.10857134150006832
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.10857134150006832
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.10857134150006832
CRYPTOCOCCOSIS	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.10857134150006832
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.10857134150006832
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.10857134150006832
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.10857134150006832
PELIZAEUS-MERZBACHER DISEASE	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.10857134150006832
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.10857134150006832
HISTIDINEMIA	0.00877193	0.10857134150006832
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.10857134150006832
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.10857134150006832
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.10857134150006832
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.10857134150006832
CORTICOBASAL SYNDROME	0.00877193	0.10857134150006832
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.10857134150006832
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.10857134150006832
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.10857134150006832
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.10857134150006832
NEUROFERRITINOPATHY	0.00877193	0.10857134150006832
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
HUNTINGTON DISEASE	0.00877193	0.10857134150006832
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.10857134150006832
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.10857134150006832
BREATH-HOLDING SPELLS	0.00877193	0.10857134150006832
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.10857134150006832
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.10857134150006832
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.10857134150006832
DIENCEPHALIC SYNDROME	0.00877193	0.10857134150006832
PINEOBLASTOMA	0.00877193	0.10857134150006832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.10857134150006832
LESCH-NYHAN SYNDROME	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.10857134150006832
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.10857134150006832
ANGELMAN SYNDROME	0.00877193	0.10857134150006832
NANCE-HORAN SYNDROME	0.00877193	0.10857134150006832
KEIPERT SYNDROME	0.00877193	0.10857134150006832
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.10857134150006832
RHEUMATIC FEVER	0.00877193	0.10857134150006832
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.10857134150006832
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.10857134150006832
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.10857134150006832
SNEDDON SYNDROME	0.00877193	0.10857134150006832
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.10857134150006832
TETRASOMY X	0.008767574	0.10851742671009915
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.008767574	0.10851742671009915
DISTAL MONOSOMY 9P	0.008767574	0.10851742671009915
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.008767574	0.10851742671009915
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.008545554	0.10576945571171621
GAUCHER DISEASE	0.00849302	0.10511923542332305
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008453974	0.10463595790056446
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008453974	0.10463595790056446
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00842938	0.10433155469934732
MENTAL RETARDATION, X-LINKED 102	0.00842938	0.10433155469934732
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00842938	0.10433155469934732
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00842938	0.10433155469934732
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00840336	0.10400950170692358
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00840336	0.10400950170692358
XYLT1-CDG	0.00840336	0.10400950170692358
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00840336	0.10400950170692358
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00840336	0.10400950170692358
ATYPICAL RETT SYNDROME	0.00840336	0.10400950170692358
THREE M SYNDROME 2; 3M2	0.00840336	0.10400950170692358
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00840336	0.10400950170692358
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00840336	0.10400950170692358
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00840336	0.10400950170692358
NEU-LAXOVA SYNDROME	0.00840336	0.10400950170692358
FEINGOLD SYNDROME 1; FGLDS1	0.00840336	0.10400950170692358
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00840336	0.10400950170692358
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00840336	0.10400950170692358
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00840336	0.10400950170692358
SPONASTRIME DYSPLASIA	0.00840336	0.10400950170692358
MEIER-GORLIN SYNDROME 8; MGORS8	0.00840336	0.10400950170692358
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008284174	0.1025343207709121
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.008270314	0.10236277371191928
BARDET-BIEDL SYNDROME 4; BBS4	0.00822202	0.101765032466104
AYME-GRIPP SYNDROME; AYGRP	0.00822202	0.101765032466104
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00822202	0.101765032466104
19P13.13 MICRODELETION SYNDROME	0.008179234	0.10123546446710927
MARDEN-WALKER SYNDROME	0.008179234	0.10123546446710927
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.008150294	0.1008772702472498
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.008127704	0.1005976708199303
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008127704	0.1005976708199303
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.008059214	0.09974996100243977
AARSKOG-SCOTT SYNDROME	0.008059214	0.09974996100243977
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.008	0.09901706146772107
LIPOID PROTEINOSIS	0.008	0.09901706146772107
PROGNATHISM, MANDIBULAR	0.008	0.09901706146772107
BLACKFAN-DIAMOND ANEMIA	0.008	0.09901706146772107
CHEILITIS GLANDULARIS	0.008	0.09901706146772107
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008	0.09901706146772107
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008	0.09901706146772107
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.008	0.09901706146772107
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.008	0.09901706146772107
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008	0.09901706146772107
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.008	0.09901706146772107
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.008	0.09901706146772107
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.008	0.09901706146772107
NOONAN SYNDROME 4; NS4	0.008	0.09901706146772107
NAKAJO-NISHIMURA SYNDROME	0.008	0.09901706146772107
FRYNS-SMEETS-THIRY SYNDROME	0.008	0.09901706146772107
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.008	0.09901706146772107
MENTAL RETARDATION, X-LINKED 19	0.008	0.09901706146772107
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.0984348906548216
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.0984348906548216
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007952964	0.0984348906548216
300270 ADRENOMYODYSTROPHY	0.007952964	0.0984348906548216
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.0984348906548216
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.0984348906548216
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00790842	0.09788356365656933
SEVERE CANAVAN DISEASE	0.007791934	0.09644180097880323
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.09644180097880323
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007791934	0.09644180097880323
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.007791934	0.09644180097880323
INFANTILE SYSTEMIC HYALINOSIS	0.007751949999999999	0.09594691370558753
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00773862	0.09578192652691696
CAMURATI-ENGELMANN DISEASE	0.00773862	0.09578192652691696
14Q12 MICRODELETION SYNDROME	0.00772476	0.09561037946792413
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007640864	0.09457198754431213
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0076047400000000005	0.09412487600325464
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0076047400000000005	0.09412487600325464
15Q26 OVERGROWTH SYNDROME	0.0076047400000000005	0.09412487600325464
MESOMELIA-SYNOSTOSES SYNDROME	0.0076047400000000005	0.09412487600325464
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.007587804	0.09391525688412748
MACROCEPHALY/AUTISM SYNDROME	0.007587804	0.09391525688412748
TIMOTHY SYNDROME; TS	0.007587804	0.09391525688412748
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007587804	0.09391525688412748
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412748
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.007587804	0.09391525688412748
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.007587804	0.09391525688412748
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.007587804	0.09391525688412748
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412748
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412748
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.007582150000000001	0.09384527657593518
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.007454094	0.09226031047302134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.007454094	0.09226031047302134
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.007454094	0.09226031047302134
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.09168249641082647
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.09168249641082647
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.09168249641082647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.09168249641082647
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.09168249641082647
DISTAL MONOSOMY 10P	0.00740741	0.09168249641082647
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082647
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082647
TRISOMY XQ28	0.00740741	0.09168249641082647
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082647
COG8-CDG	0.00740741	0.09168249641082647
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.09168249641082647
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.09168249641082647
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082647
DPM1-CDG	0.00740741	0.09168249641082647
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082647
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.09168249641082647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082647
CROME SYNDROME	0.00740741	0.09168249641082647
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.09168249641082647
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082647
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.09168249641082647
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.09168249641082647
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.09168249641082647
MONOSOMY 5P	0.00740741	0.09168249641082647
LOWRY-MACLEAN SYNDROME	0.00740741	0.09168249641082647
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082647
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082647
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082647
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.09168249641082647
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082647
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082647
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.09168249641082647
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.09168249641082647
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.007260204	0.0898605082170243
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	0.08982040630712987
WYBURN-MASON SYNDROME	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	0.08982040630712987
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	0.08982040630712987
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.007256964	0.08982040630712987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.08982040630712987
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	0.08982040630712987
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	0.08982040630712987
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.08982040630712987
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.08982040630712987
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.08982040630712987
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007256964	0.08982040630712987
MEDULLOBLASTOMA	0.007256964	0.08982040630712987
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	0.08982040630712987
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.007256964	0.08982040630712987
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.08982040630712987
AICARDI-GOUTIÈRES SYNDROME	0.007256964	0.08982040630712987
CITRULLINEMIA, CLASSIC	0.007256964	0.08982040630712987
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.08982040630712987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.08982040630712987
NARP SYNDROME	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	0.08982040630712987
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.08982040630712987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.007256964	0.08982040630712987
JOUBERT SYNDROME 14	0.007256964	0.08982040630712987
MACHADO-JOSEPH DISEASE TYPE 2	0.00724638	0.08968940673480809
PREECLAMPSIA	0.00724638	0.08968940673480809
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.08968940673480809
MACHADO-JOSEPH DISEASE TYPE 3	0.00724638	0.08968940673480809
MACHADO-JOSEPH DISEASE TYPE 1	0.00724638	0.08968940673480809
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480809
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00724638	0.08968940673480809
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480809
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480809
HEREDITARY HYPEREKPLEXIA	0.00724638	0.08968940673480809
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480809
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.08716286264013234
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013234
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00704225	0.08716286264013234
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.08716286264013234
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00704225	0.08716286264013234
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.08716286264013234
HYPERLEXIA	0.00704225	0.08716286264013234
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0069085399999999995	0.0855079162290262
OROFACIODIGITAL SYNDROME IX; OFD9	0.006718394	0.08315445395779605
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.006718394	0.08315445395779605
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.006718394	0.08315445395779605
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006718394	0.08315445395779605
GALLOWAY-MOWAT SYNDROME	0.006718394	0.08315445395779605
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.006718394	0.08315445395779605
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.006718394	0.08315445395779605
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.006718394	0.08315445395779605
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006718394	0.08315445395779605
CEDNIK SYNDROME	0.006718394	0.08315445395779605
PELGER-HUET ANOMALY; PHA	0.006718394	0.08315445395779605
3Q29 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779605
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779605
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006718394	0.08315445395779605
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.006718394	0.08315445395779605
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313473
RHABDOID TUMOR	0.00671141	0.08306801206313473
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313473
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313473
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313473
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313473
GRAFT VERSUS HOST DISEASE	0.00671141	0.08306801206313473
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313473
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.08306801206313473
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313473
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313473
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313473
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313473
BEHCET SYNDROME	0.00671141	0.08306801206313473
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.08306801206313473
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313473
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313473
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313473
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313473
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313473
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00671141	0.08306801206313473
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313473
BETA-THALASSEMIA	0.00671141	0.08306801206313473
9Q21.13 MICRODELETION SYNDROME	0.00671141	0.08306801206313473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313473
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313473
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313473
KAWASAKI DISEASE	0.00671141	0.08306801206313473
3C SYNDROME	0.006643314000000001	0.0822251788359215
OROFACIODIGITAL SYNDROME TYPE 6	0.006643314000000001	0.0822251788359215
PETERS-PLUS SYNDROME; PTRPLS	0.006643314000000001	0.0822251788359215
PETERS PLUS SYNDROME	0.006643314000000001	0.0822251788359215
CORNEODERMATOOSSEOUS SYNDROME	0.006594630000000001	0.08162261050835969
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.006404794	0.0792729851482614
SSR4-CDG	0.006404793999999999	0.07927298514826138
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006404793999999999	0.07927298514826138
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006404793999999999	0.07927298514826138
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.006404793999999999	0.07927298514826138
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006404793999999999	0.07927298514826138
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.006404793999999999	0.07927298514826138
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.006404793999999999	0.07927298514826138
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006404793999999999	0.07927298514826138
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.006404793999999999	0.07927298514826138
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006284774	0.0777874816835919
MATERNAL PHENYLKETONURIA	0.006284774	0.0777874816835919
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0062483239999999995	0.0773363351972796
COFFIN-SIRIS SYNDROME 3; CSS3	0.0062483239999999995	0.0773363351972796
COFFIN-SIRIS SYNDROME 4; CSS4	0.0062483239999999995	0.0773363351972796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0062483239999999995	0.0773363351972796
GENITOPATELLAR SYNDROME	0.0062483239999999995	0.0773363351972796
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.07640205971380092
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.07640205971380092
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00617284	0.07640205971380092
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00617284	0.07640205971380092
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.07640205971380092
BRITTLE CORNEA SYNDROME	0.00617284	0.07640205971380092
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.07640205971380092
TEETH, FUSED	0.00617284	0.07640205971380092
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.07640205971380092
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00617284	0.07640205971380092
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.07640205971380092
JUVENILE PAGET DISEASE	0.00617284	0.07640205971380092
SEVERE COMBINED IMMUNODEFICIENCY	0.00617284	0.07640205971380092
ISOLATED HEMIHYPERPLASIA	0.00617284	0.07640205971380092
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00617284	0.07640205971380092
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.00617284	0.07640205971380092
8Q21.11 MICRODELETION SYNDROME	0.00617284	0.07640205971380092
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00617284	0.07640205971380092
TOOTH SIZE	0.00617284	0.07640205971380092
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.07640205971380092
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.07640205971380092
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.07640205971380092
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.07640205971380092
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00617284	0.07640205971380092
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.07640205971380092
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.07640205971380092
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00617284	0.07640205971380092
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.07640205971380092
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.07640205971380092
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00617284	0.07640205971380092
DEAFNESS-CRANIOFACIAL SYNDROME	0.00617284	0.07640205971380092
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00617284	0.07640205971380092
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.07640205971380092
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.07640205971380092
BUSCHKE-OLLENDORFF SYNDROME	0.00617284	0.07640205971380092
MOLAR I REINCLUSION	0.00617284	0.07640205971380092
DENS EVAGINATUS	0.00617284	0.07640205971380092
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.07640205971380092
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00617284	0.07640205971380092
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00617284	0.07640205971380092
SPLIT LOWER LIP	0.00617284	0.07640205971380092
INCISORS, FUSED MANDIBULAR	0.00617284	0.07640205971380092
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.07640205971380092
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00617284	0.07640205971380092
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.07640205971380092
FAMILIAL TUMORAL CALCINOSIS	0.00617284	0.07640205971380092
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00617284	0.07640205971380092
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.07640205971380092
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00617284	0.07640205971380092
LAMELLAR ICHTHYOSIS	0.00617284	0.07640205971380092
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.07640205971380092
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00617284	0.07640205971380092
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00617284	0.07640205971380092
BANGSTAD SYNDROME	0.00617284	0.07640205971380092
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00617284	0.07640205971380092
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00617284	0.07640205971380092
VELO-FACIAL-SKELETAL SYNDROME	0.00617284	0.07640205971380092
NON-DISTAL TRISOMY 13Q	0.00617284	0.07640205971380092
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.07640205971380092
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.07640205971380092
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00617284	0.07640205971380092
CHOPS SYNDROME; CHOPS	0.006128303999999999	0.0758508317326101
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006101114	0.0755142974949467
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.006101114	0.0755142974949467
LATHOSTEROLOSIS	0.006101114	0.0755142974949467
MOSAIC TRISOMY 9	0.006101114	0.0755142974949467
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.006101114	0.0755142974949467
XQ27.3Q28 DUPLICATION SYNDROME	0.006101114	0.0755142974949467
NOONAN SYNDROME 11; NS11	0.006101114	0.0755142974949467
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.006101114	0.0755142974949467
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006101114	0.0755142974949467
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006101114	0.0755142974949467
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.006101114	0.0755142974949467
JEUNE SYNDROME	0.006097760000000001	0.07547278459192636
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.006097760000000001	0.07547278459192636
INCONTINENTIA PIGMENTI	0.006010034	0.0743869882501367
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.0743869882501367
8Q12 MICRODUPLICATION SYNDROME	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.0743869882501367
CHROMOSOME 15Q25 DELETION SYNDROME	0.006010034	0.0743869882501367
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.0743869882501367
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.0743869882501367
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.0743869882501367
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.006010034	0.0743869882501367
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.006010034	0.0743869882501367
8P23.1 MICRODELETION SYNDROME	0.006010034	0.0743869882501367
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.006010034	0.0743869882501367
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00585924	0.07252059090426624
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00585924	0.07252059090426624
CRISS-CROSS HEART	0.00585924	0.07252059090426624
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00573922	0.07103508743959676
LARON SYNDROME	0.00573922	0.07103508743959676
ATELOSTEOGENESIS TYPE II	0.00573922	0.07103508743959676
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00573922	0.07103508743959676
PALLISTER-KILLIAN SYNDROME	0.005702769999999999	0.07058394095328446
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00558275	0.06909843748861498
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00558275	0.06909843748861498
RIN2 SYNDROME	0.00558275	0.06909843748861498
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00558275	0.06909843748861498
CAMPOMELIA, CUMMING TYPE	0.00558275	0.06909843748861498
BASAL CELL NEVUS SYNDROME	0.00558275	0.06909843748861498
NOSE, ANOMALOUS SHAPE OF	0.00555556	0.06876190325095156
ZIMMERMANN-LABAND SYNDROME	0.00555556	0.06876190325095156
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00555556	0.06876190325095156
JOHNSON NEUROECTODERMAL SYNDROME	0.00555556	0.06876190325095156
KAPUR-TORIELLO SYNDROME	0.00555556	0.06876190325095156
260150 PALANT CLEFT PALATE SYNDROME	0.00555556	0.06876190325095156
CONGENITAL HYDROCEPHALUS	0.00555556	0.06876190325095156
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00555556	0.06876190325095156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00555556	0.06876190325095156
3M SYNDROME	0.00555556	0.06876190325095156
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00555556	0.06876190325095156
OROFACIAL CLEFT 15	0.00555556	0.06876190325095156
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.06876190325095156
OROFACIODIGITAL SYNDROME III	0.00555556	0.06876190325095156
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00555556	0.06876190325095156
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00555556	0.06876190325095156
OROFACIODIGITAL SYNDROME TYPE 3	0.00555556	0.06876190325095156
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00555556	0.06876190325095156
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00555556	0.06876190325095156
DISTAL MONOSOMY 7Q36	0.00555556	0.06876190325095156
THAKKER-DONNAI SYNDROME	0.00555556	0.06876190325095156
BARBER-SAY SYNDROME; BBRSAY	0.00555556	0.06876190325095156
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00555556	0.06876190325095156
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00555556	0.06876190325095156
BEEMER-ERTBRUGGEN SYNDROME	0.00555556	0.06876190325095156
CHROMOSOME 13Q14 DELETION SYNDROME	0.00555556	0.06876190325095156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00555556	0.06876190325095156
BARBER-SAY SYNDROME	0.00555556	0.06876190325095156
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00555556	0.06876190325095156
CERNUNNOS-XLF DEFICIENCY	0.00555556	0.06876190325095156
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733957
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733957
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.06763459400614155
MICROTIA	0.00546448	0.06763459400614155
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00546448	0.06763459400614155
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614155
NEUROFIBROMATOSIS TYPE 1	0.00546448	0.06763459400614155
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.06763459400614155
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.06763459400614155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00546448	0.06763459400614155
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614155
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.06763459400614155
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.06763459400614155
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.06541183425604878
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.005284894	0.06541183425604878
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005284894	0.06541183425604878
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005284894	0.06541183425604878
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.005284894	0.06541183425604878
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.005284894	0.06541183425604878
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.06541183425604878
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.06541183425604878
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0050910040000000005	0.06301203200005173
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0050910040000000005	0.06301203200005173
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0050910040000000005	0.06301203200005173
CHÉDIAK-HIGASHI SYNDROME	0.0050910040000000005	0.06301203200005173
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0050910040000000005	0.06301203200005173
MUCOLIPIDOSIS IV; ML4	0.0050910040000000005	0.06301203200005173
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005173
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0050910040000000005	0.06301203200005173
L1 SYNDROME	0.004989994	0.06176181782769492
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769492
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.060971117083344434
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.060971117083344434
GENIOSPASM 1; GSM1	0.00492611	0.060971117083344434
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.060971117083344434
PANIC DISORDER 1	0.00492611	0.060971117083344434
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.060971117083344434
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.060971117083344434
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.060971117083344434
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004763933999999999	0.058963843213270785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.05865944001205365
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.05865944001205365
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00473934	0.05865944001205365
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00473934	0.05865944001205365
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.05865944001205365
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.05865944001205365
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.05865944001205365
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.05865944001205365
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.05865944001205365
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004594134000000001	0.056862206083618416
GALACTOSEMIA	0.004594134000000001	0.056862206083618416
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004594134000000001	0.056862206083618416
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004594134000000001	0.056862206083618416
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004594134000000001	0.056862206083618416
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.056862206083618416
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004594134000000001	0.056862206083618416
WEAVER SYNDROME	0.004594134000000001	0.056862206083618416
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004594134000000001	0.056862206083618416
SHASHI-PENA SYNDROME; SHAPNS	0.004594134000000001	0.056862206083618416
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004594134000000001	0.056862206083618416
CANAVAN DISEASE	0.004594134000000001	0.056862206083618416
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.056862206083618416
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004594134000000001	0.056862206083618416
JOUBERT SYNDROME	0.004594134000000001	0.056862206083618416
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004594134000000001	0.056862206083618416
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004594134000000001	0.056862206083618416
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004594134000000001	0.056862206083618416
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004594134000000001	0.056862206083618416
PEHO SYNDROME; PEHO	0.004594134000000001	0.056862206083618416
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004594134000000001	0.056862206083618416
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.004594134000000001	0.056862206083618416
METHYLMALONIC ACIDURIA, CBLB TYPE	0.004594134000000001	0.056862206083618416
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00454545	0.0562596377560566
ALACRIMA, CONGENITAL	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.0562596377560566
CHRONIC GRAFT VERSUS HOST DISEASE	0.00454545	0.0562596377560566
NEOVASCULAR GLAUCOMA	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.0562596377560566
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.0562596377560566
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.0562596377560566
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.0562596377560566
LEUKONYCHIA TOTALIS	0.00454545	0.0562596377560566
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.0562596377560566
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.0562596377560566
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.0562596377560566
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00454545	0.0562596377560566
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.0562596377560566
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.0562596377560566
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.0562596377560566
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.0562596377560566
CORNEAL FLECK DYSTROPHY	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.0562596377560566
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.0562596377560566
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.0562596377560566
BLAU SYNDROME	0.00454545	0.0562596377560566
REACTIVE ARTHRITIS	0.00454545	0.0562596377560566
COGAN SYNDROME	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.0562596377560566
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.0562596377560566
CONE DYSTROPHY 4	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMATISM	0.00454545	0.0562596377560566
AMOEBIC KERATITIS	0.00454545	0.0562596377560566
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.0562596377560566
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.00454545	0.0562596377560566
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 4	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.0562596377560566
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 10	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00454545	0.0562596377560566
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.0562596377560566
BRADYOPSIA	0.00454545	0.0562596377560566
OLIGOCONE TRICHROMACY	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA	0.00454545	0.0562596377560566
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.0562596377560566
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS 16	0.00454545	0.0562596377560566
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.0562596377560566
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.0562596377560566
ACHROMATOPSIA 7; ACHM7	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.0562596377560566
STEVENS-JOHNSON SYNDROME	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 79	0.00454545	0.0562596377560566
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.0562596377560566
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.0562596377560566
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 16	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.0562596377560566
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.0562596377560566
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.0562596377560566
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.0562596377560566
ACHROMATOPSIA	0.00454545	0.0562596377560566
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.0562596377560566
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.0562596377560566
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00454545	0.0562596377560566
ALPORT SYNDROME	0.00454545	0.0562596377560566
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00454545	0.0562596377560566
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 4	0.00454545	0.0562596377560566
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.0562596377560566
IDIOPATHIC PANUVEITIS	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.0562596377560566
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.0562596377560566
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00454545	0.0562596377560566
IRVAN SYNDROME	0.00454545	0.0562596377560566
TYROSINEMIA TYPE 2	0.00454545	0.0562596377560566
ALACRIMA	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.0562596377560566
SJÖGREN-LARSSON SYNDROME	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 17	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.0562596377560566
FLOTCH SYNDROME	0.00454545	0.0562596377560566
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 2	0.00454545	0.0562596377560566
CONE DYSTROPHY 3	0.00454545	0.0562596377560566
ALBINISM, OCULAR, TYPE I	0.00454545	0.0562596377560566
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.0562596377560566
CONE ROD DYSTROPHY	0.00454545	0.0562596377560566
JALILI SYNDROME	0.00454545	0.0562596377560566
HIDROTIC ECTODERMAL DYSPLASIA	0.00454545	0.0562596377560566
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.0562596377560566
EEC SYNDROME	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.0562596377560566
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA SYNDROME	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.0562596377560566
SCRUB TYPHUS	0.00454545	0.0562596377560566
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.0562596377560566
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.055009423583699785
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.055009423583699785
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.055009423583699785
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.055009423583699785
ACERULOPLASMINEMIA	0.00444444	0.055009423583699785
GIANT CELL ARTERITIS	0.00444444	0.055009423583699785
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.055009423583699785
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.055009423583699785
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.055009423583699785
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.055009423583699785
CADASIL	0.00444444	0.055009423583699785
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.055009423583699785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.055009423583699785
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.055009423583699785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.055009423583699785
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.055009423583699785
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.055009423583699785
TRIMETHYLAMINURIA	0.00444444	0.055009423583699785
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.055009423583699785
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.055009423583699785
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.055009423583699785
CENTRAL NEUROCYTOMA	0.00444444	0.055009423583699785
GLUCAGONOMA	0.00444444	0.055009423583699785
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.055009423583699785
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.055009423583699785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.05242450893128881
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.05242450893128881
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.05242450893128881
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004235594	0.05242450893128881
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.05242450893128881
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.05242450893128881
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.05242450893128881
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004235594	0.05242450893128881
SLC35A2-CDG	0.004235594	0.05242450893128881
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004235594	0.05242450893128881
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004235594	0.05242450893128881
SRD5A3-CDG	0.004235594	0.05242450893128881
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.004235594	0.05242450893128881
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.004235594	0.05242450893128881
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.004235594	0.05242450893128881
MONOSOMY 13Q34	0.004235594	0.05242450893128881
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.05242450893128881
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.05242450893128881
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.004235594	0.05242450893128881
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.05242450893128881
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.05242450893128881
SPINOCEREBELLAR ATAXIA TYPE 13	0.004235594	0.05242450893128881
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.05242450893128881
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004235594	0.05242450893128881
FREE SIALIC ACID STORAGE DISEASE	0.004235594	0.05242450893128881
SYNDROMIC DIARRHEA	0.004235594	0.05242450893128881
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.05242450893128881
RING CHROMOSOME 12 SYNDROME	0.004235594	0.05242450893128881
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.05242450893128881
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.05242450893128881
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.05242450893128881
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004235594	0.05242450893128881
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.05242450893128881
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.05242450893128881
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.004235594	0.05242450893128881
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004235594	0.05242450893128881
TRANSALDOLASE DEFICIENCY	0.004235594	0.05242450893128881
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.004235594	0.05242450893128881
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.05242450893128881
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.004235594	0.05242450893128881
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.05242450893128881
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.05048785898030703
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.004079124	0.05048785898030703
THYROID HYPOPLASIA	0.004079124	0.05048785898030703
INFANTILE SIALIC ACID STORAGE DISEASE	0.004079124	0.05048785898030703
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004079124	0.05048785898030703
SIALIDOSIS TYPE 2	0.004079124	0.05048785898030703
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.05048785898030703
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004079124	0.05048785898030703
TETRASOMY 5P	0.004079124	0.05048785898030703
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004079124	0.05048785898030703
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004079124	0.05048785898030703
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004079124	0.05048785898030703
MULTIPLE SULFATASE DEFICIENCY	0.004079124	0.05048785898030703
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004079124	0.05048785898030703
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.05048785898030703
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.05010981183962328
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.05010981183962328
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.05010981183962328
INCLUSION BODY MYOSITIS	0.00404858	0.05010981183962328
SYSTEMIC SCLEROSIS	0.00404858	0.05010981183962328
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.05010981183962328
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.05010981183962328
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.05010981183962328
APERT SYNDROME	0.00404858	0.05010981183962328
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.05010981183962328
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.05010981183962328
AORTIC ARCH DEFECTS	0.00404858	0.05010981183962328
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.05010981183962328
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.05010981183962328
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.05010981183962328
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.05010981183962328
OHDO SYNDROME	0.00404858	0.05010981183962328
DERMATOMYOSITIS	0.00404858	0.05010981183962328
HYPOADRENOCORTICISM, FAMILIAL	0.00404858	0.05010981183962328
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.05010981183962328
NEMALINE MYOPATHY 4	0.00404858	0.05010981183962328
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.05010981183962328
GMS SYNDROME	0.00404858	0.05010981183962328
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00404858	0.05010981183962328
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00404858	0.05010981183962328
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.05010981183962328
COHEN SYNDROME	0.00404858	0.05010981183962328
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.05010981183962328
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.05010981183962328
ACROCARDIOFACIAL SYNDROME	0.00404858	0.05010981183962328
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.05010981183962328
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.05010981183962328
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.05010981183962328
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.05010981183962328
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00404858	0.05010981183962328
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.05010981183962328
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.05010981183962328
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00404858	0.05010981183962328
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00404858	0.05010981183962328
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.05010981183962328
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00404858	0.05010981183962328
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00404858	0.05010981183962328
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.05010981183962328
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00404858	0.05010981183962328
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.05010981183962328
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.05010981183962328
PIERRE ROBIN SYNDROME	0.00404858	0.05010981183962328
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.05010981183962328
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00404858	0.05010981183962328
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.05010981183962328
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.05010981183962328
601095 HARROD SYNDROME	0.00369004	0.04567211468729368
CROUZON DISEASE	0.00369004	0.04567211468729368
SÉZARY SYNDROME	0.00369004	0.04567211468729368
KENNERKNECHT SYNDROME	0.00369004	0.04567211468729368
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.04567211468729368
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.04567211468729368
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.04567211468729368
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.04567211468729368
BETA-MANNOSIDOSIS	0.00369004	0.04567211468729368
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.04567211468729368
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.04567211468729368
EPILEPSY-TELANGIECTASIA	0.00369004	0.04567211468729368
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.04567211468729368
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.04567211468729368
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.04567211468729368
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.04567211468729368
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.04567211468729368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.04567211468729368
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.04567211468729368
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.04567211468729368
JUVENILE POLYPOSIS SYNDROME	0.00369004	0.04567211468729368
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.04567211468729368
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.04567211468729368
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.04567211468729368
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.04567211468729368
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.04567211468729368
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.04567211468729368
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.04567211468729368
ISOLATED BILIARY ATRESIA	0.00369004	0.04567211468729368
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.04567211468729368
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.04567211468729368
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.04567211468729368
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.04567211468729368
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.04567211468729368
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.04567211468729368
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.04567211468729368
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00369004	0.04567211468729368
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.04567211468729368
HAIRY ELBOWS	0.00369004	0.04567211468729368
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.04567211468729368
MCDONOUGH SYNDROME	0.00369004	0.04567211468729368
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.04567211468729368
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.04567211468729368
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.04567211468729368
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.04567211468729368
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.04567211468729368
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.04567211468729368
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.04567211468729368
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.04567211468729368
ZECHI-CEIDE SYNDROME	0.00369004	0.04567211468729368
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.04567211468729368
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.04567211468729368
LICHTENSTEIN SYNDROME	0.00369004	0.04567211468729368
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.04567211468729368
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.04567211468729368
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.04567211468729368
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.04567211468729368
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.04567211468729368
UROFACIAL SYNDROME	0.00369004	0.04567211468729368
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.04567211468729368
MUCOLIPIDOSIS III GAMMA	0.00353357	0.0437354647363119
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.0437354647363119
X-LINKED ACROGIGANTISM	0.00353357	0.0437354647363119
HURLER-SCHEIE SYNDROME	0.00353357	0.0437354647363119
FRYNS SYNDROME; FRNS	0.00353357	0.0437354647363119
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00353357	0.0437354647363119
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00353357	0.0437354647363119
GALACTOSIALIDOSIS	0.00353357	0.0437354647363119
MORQUIO SYNDROME A	0.00353357	0.0437354647363119
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.0437354647363119
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00353357	0.0437354647363119
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00353357	0.0437354647363119
NEURAMINIDASE DEFICIENCY	0.00353357	0.0437354647363119
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00353357	0.0437354647363119
SANDHOFF DISEASE	0.00353357	0.0437354647363119
GM1 GANGLIOSIDOSIS	0.00353357	0.0437354647363119
GRFOMA	0.00353357	0.0437354647363119
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00353357	0.0437354647363119
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0437354647363119
NF1-MICRODELETION SYNDROME	0.00353357	0.0437354647363119
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.0437354647363119
FRANK-TER HAAR SYNDROME; FTHS	0.00353357	0.0437354647363119
ALAGILLE SYNDROME	0.00353357	0.0437354647363119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.0437354647363119
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.0437354647363119
FRONTOMETAPHYSEAL DYSPLASIA	0.00353357	0.0437354647363119
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.0437354647363119
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.0437354647363119
CRANIODIAPHYSEAL DYSPLASIA	0.00353357	0.0437354647363119
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.0437354647363119
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.0437354647363119
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00353357	0.0437354647363119
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00353357	0.0437354647363119
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.0437354647363119
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.0437354647363119
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.0437354647363119
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0437354647363119
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.0437354647363119
PITUITARY GIGANTISM	0.00353357	0.0437354647363119
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.0437354647363119
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.0437354647363119
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.0437354647363119
MUCOLIPIDOSIS TYPE III	0.00353357	0.0437354647363119
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.0336008704609677
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.0336008704609677
EMANUEL SYNDROME	0.0027147539999999998	0.0336008704609677
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.0336008704609677
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.0336008704609677
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027147539999999998	0.0336008704609677
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.0336008704609677
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0027147539999999998	0.0336008704609677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027147539999999998	0.0336008704609677
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.0336008704609677
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027147539999999998	0.0336008704609677
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027147539999999998	0.0336008704609677
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.0336008704609677
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0027147539999999998	0.0336008704609677
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027147539999999998	0.0336008704609677
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0027147539999999998	0.0336008704609677
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027147539999999998	0.0336008704609677
PEHO SYNDROME	0.0027147539999999998	0.0336008704609677
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0027147539999999998	0.0336008704609677
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027147539999999998	0.0336008704609677
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.0027147539999999998	0.0336008704609677
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027147539999999998	0.0336008704609677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0027147539999999998	0.0336008704609677
AU-KLINE SYNDROME; AUKS	0.0027147539999999998	0.0336008704609677
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
JOUBERT SYNDROME WITH RENAL DEFECT	0.0027147539999999998	0.0336008704609677
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0027147539999999998	0.0336008704609677
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0027147539999999998	0.0336008704609677
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027147539999999998	0.0336008704609677
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027147539999999998	0.0336008704609677
RFT1-CDG	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027147539999999998	0.0336008704609677
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.0336008704609677
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
8P11.2 DELETION SYNDROME	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027147539999999998	0.0336008704609677
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027147539999999998	0.0336008704609677
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0027147539999999998	0.0336008704609677
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0027147539999999998	0.0336008704609677
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0027147539999999998	0.0336008704609677
STT3B-CDG	0.0027147539999999998	0.0336008704609677
STT3A-CDG	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0027147539999999998	0.0336008704609677
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027147539999999998	0.0336008704609677
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0027147539999999998	0.0336008704609677
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027147539999999998	0.0336008704609677
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.0336008704609677
PMM2-CDG	0.0027147539999999998	0.0336008704609677
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.0336008704609677
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.0336008704609677
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.0336008704609677
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027147539999999998	0.0336008704609677
HAREL-YOON SYNDROME; HAYOS	0.0027147539999999998	0.0336008704609677
PONTINE TEGMENTAL CAP DYSPLASIA	0.0027147539999999998	0.0336008704609677
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027147539999999998	0.0336008704609677
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027147539999999998	0.0336008704609677
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027147539999999998	0.0336008704609677
MONOSOMY 9Q22.3	0.0027147539999999998	0.0336008704609677
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027147539999999998	0.0336008704609677
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.0336008704609677
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.0336008704609677
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027147539999999998	0.0336008704609677
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0027147539999999998	0.0336008704609677
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027147539999999998	0.0336008704609677
PEHO-LIKE SYNDROME; PEHOL	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027147539999999998	0.0336008704609677
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025947339999999996	0.03211536699629822
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.03211536699629822
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0025947339999999996	0.03211536699629822
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0025947339999999996	0.03211536699629822
TEMTAMY SYNDROME; TEMTYS	0.0025947339999999996	0.03211536699629822
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.03211536699629822
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.03211536699629822
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0025947339999999996	0.03211536699629822
TRISOMY 8Q	0.0025947339999999996	0.03211536699629822
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.03211536699629822
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0025947339999999996	0.03211536699629822
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.03211536699629822
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025947339999999996	0.03211536699629822
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.03211536699629822
ROBERTS SYNDROME	0.0025947339999999996	0.03211536699629822
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0025947339999999996	0.03211536699629822
GRACILE BONE DYSPLASIA; GCLEB	0.0025947339999999996	0.03211536699629822
ADAMS-OLIVER SYNDROME 1; AOS1	0.0025947339999999996	0.03211536699629822
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.03211536699629822
RAINE SYNDROME	0.0025947339999999996	0.03211536699629822
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0025947339999999996	0.03211536699629822
RUVALCABA SYNDROME	0.0025947339999999996	0.03211536699629822
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0025947339999999996	0.03211536699629822
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.03211536699629822
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0025947339999999996	0.03211536699629822
CODAS SYNDROME	0.0025947339999999996	0.03211536699629822
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.03211536699629822
CINCA SYNDROME	0.0025947339999999996	0.03211536699629822
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.03211536699629822
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0025947339999999996	0.03211536699629822
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.03211536699629822
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0025947339999999996	0.03211536699629822
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.03211536699629822
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.03211536699629822
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.03211536699629822
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.03211536699629822
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0021691999999999996	0.026848476216972565
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.026848476216972565
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0021691999999999996	0.026848476216972565
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.026848476216972565
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.026848476216972565
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.026848476216972565
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.026848476216972565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0021691999999999996	0.026848476216972565
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.026848476216972565
KABUKI SYNDROME	0.0021691999999999996	0.026848476216972565
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.026848476216972565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.026848476216972565
SMITH-KINGSMORE SYNDROME; SKS	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.026848476216972565
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.026848476216972565
SANDIFER SYNDROME	0.0021691999999999996	0.026848476216972565
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.026848476216972565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0021691999999999996	0.026848476216972565
DESMOSTEROLOSIS	0.0021691999999999996	0.026848476216972565
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.026848476216972565
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0021691999999999996	0.026848476216972565
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.026848476216972565
CITRULLINEMIA TYPE I	0.0021691999999999996	0.026848476216972565
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.026848476216972565
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.026848476216972565
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.026848476216972565
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0021691999999999996	0.026848476216972565
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.026848476216972565
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.026848476216972565
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0021691999999999996	0.026848476216972565
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0021691999999999996	0.026848476216972565
COMBINED SAPOSIN DEFICIENCY	0.0021691999999999996	0.026848476216972565
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0021691999999999996	0.026848476216972565
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.026848476216972565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0021691999999999996	0.026848476216972565
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.026848476216972565
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0021691999999999996	0.026848476216972565
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.026848476216972565
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.026848476216972565
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.026848476216972565
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.026848476216972565
TEMPLE SYNDROME	0.0021691999999999996	0.026848476216972565
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.026848476216972565
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.026848476216972565
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.026848476216972565
RETINITIS PIGMENTOSA 59; RP59	0.0021691999999999996	0.026848476216972565
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.026848476216972565
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0021691999999999996	0.026848476216972565
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.026848476216972565
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.026848476216972565
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.026848476216972565
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.026848476216972565
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.026848476216972565
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.026848476216972565
CRISPONI SYNDROME	0.0021691999999999996	0.026848476216972565
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.026848476216972565
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.026848476216972565
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.026848476216972565
CHARGE SYNDROME	0.0021691999999999996	0.026848476216972565
COCKAYNE SYNDROME	0.0021691999999999996	0.026848476216972565
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.026848476216972565
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.026848476216972565
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0021691999999999996	0.026848476216972565
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.026848476216972565
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.026848476216972565
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.026848476216972565
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0021691999999999996	0.026848476216972565
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0021691999999999996	0.026848476216972565
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0021691999999999996	0.026848476216972565
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0021691999999999996	0.026848476216972565
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.026848476216972565
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.026848476216972565
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.026848476216972565
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.026848476216972565
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.026848476216972565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0021691999999999996	0.026848476216972565
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.026848476216972565
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0021691999999999996	0.026848476216972565
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.026848476216972565
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.026848476216972565
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.026848476216972565
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.026848476216972565
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.026848476216972565
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.026848476216972565
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.025362972752303082
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.025362972752303082
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.025362972752303082
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00204918	0.025362972752303082
CRANIOSYNOSTOSIS 2	0.00204918	0.025362972752303082
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.025362972752303082
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.025362972752303082
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.025362972752303082
LARSEN SYNDROME	0.00204918	0.025362972752303082
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.025362972752303082
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.025362972752303082
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00204918	0.025362972752303082
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00204918	0.025362972752303082
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00204918	0.025362972752303082
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00204918	0.025362972752303082
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.025362972752303082
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00204918	0.025362972752303082
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.025362972752303082
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.025362972752303082
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00204918	0.025362972752303082
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.025362972752303082
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.025362972752303082
PYCNODYSOSTOSIS	0.00204918	0.025362972752303082
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00204918	0.025362972752303082
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.025362972752303082
SATOYOSHI SYNDROME	0.00204918	0.025362972752303082
EIKEN SYNDROME	0.00204918	0.025362972752303082
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.025362972752303082
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.025362972752303082
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.025362972752303082
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.025362972752303082
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.025362972752303082
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.025362972752303082
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.025362972752303082
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.025362972752303082
OROFACIODIGITAL SYNDROME I; OFD1	0.00204918	0.025362972752303082
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.025362972752303082
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.025362972752303082
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.025362972752303082
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.025362972752303082
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.025362972752303082
ADAMS-OLIVER SYNDROME 5; AOS5	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.025362972752303082
POTOCKI-SHAFFER SYNDROME	0.00204918	0.025362972752303082
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00204918	0.025362972752303082
GRANGE SYNDROME; GRNG	0.00204918	0.025362972752303082
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.025362972752303082
RHYNS SYNDROME; RHYNS	0.00204918	0.025362972752303082
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.025362972752303082
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.025362972752303082
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.025362972752303082
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.025362972752303082
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00204918	0.025362972752303082
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.025362972752303082
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.025362972752303082
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.025362972752303082
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.025362972752303082
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.025362972752303082
PFEIFFER SYNDROME	0.00204918	0.025362972752303082
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.025362972752303082
608028 THAI SYMPHALANGISM SYNDROME	0.00204918	0.025362972752303082
THANATOPHORIC DYSPLASIA	0.00204918	0.025362972752303082
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.025362972752303082
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00204918	0.025362972752303082
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00204918	0.025362972752303082
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.025362972752303082
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.025362972752303082
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.025362972752303082
SILLENCE SYNDROME	0.00204918	0.025362972752303082
CRANIOECTODERMAL DYSPLASIA 1	0.00204918	0.025362972752303082
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.025362972752303082
SHORT SYNDROME	0.00204918	0.025362972752303082
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303082
PSEUDOACHONDROPLASIA	0.00204918	0.025362972752303082
ODONTOCHONDRODYSPLASIA; ODCD	0.00204918	0.025362972752303082
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.025362972752303082
ATELOSTEOGENESIS TYPE I	0.00204918	0.025362972752303082
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303082
BANKI SYNDROME	0.00204918	0.025362972752303082
SYMPHALANGISM, DISTAL	0.00204918	0.025362972752303082
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303082
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.025362972752303082
THANATOPHORIC DYSPLASIA TYPE 1	0.00204918	0.025362972752303082
LERI PLEONOSTEOSIS	0.00204918	0.025362972752303082
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.025362972752303082
20P13 MICRODELETION SYNDROME	0.00204918	0.025362972752303082
SUMMITT SYNDROME	0.00204918	0.025362972752303082
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.025362972752303082
ACRODYSOSTOSIS	0.00204918	0.025362972752303082
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00204918	0.025362972752303082
METATROPIC DYSPLASIA	0.00204918	0.025362972752303082
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.025362972752303082
GENITOPALATOCARDIAC SYNDROME	0.00204918	0.025362972752303082
MONOSOMY 13Q14	0.00204918	0.025362972752303082
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00204918	0.025362972752303082
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.025362972752303082
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.025362972752303082
DISTAL TRISOMY 5Q	0.00204918	0.025362972752303082
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.025362972752303082
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.025362972752303082
FIBROCHONDROGENESIS	0.00204918	0.025362972752303082
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.025362972752303082
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00204918	0.025362972752303082
ENG-STROM SYNDROME	0.00204918	0.025362972752303082
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.025362972752303082
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00204918	0.025362972752303082
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.025362972752303082
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00204918	0.025362972752303082
JACOBSEN SYNDROME	0.00204918	0.025362972752303082
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00204918	0.025362972752303082
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.025362972752303082
COOKS SYNDROME	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.025362972752303082
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.025362972752303082
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303082
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.025362972752303082
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.025362972752303082
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00204918	0.025362972752303082
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.025362972752303082
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.025362972752303082
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.025362972752303082
ACROCALLOSAL SYNDROME; ACLS	0.00204918	0.025362972752303082
WOLCOTT-RALLISON SYNDROME	0.00204918	0.025362972752303082
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.025362972752303082
HYPERTELORISM, TEEBI TYPE	0.00204918	0.025362972752303082
RADIO-RENAL SYNDROME	0.00204918	0.025362972752303082
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00204918	0.025362972752303082
ADAMS-OLIVER SYNDROME	0.00204918	0.025362972752303082
NON-DISTAL MONOSOMY 10Q	0.00204918	0.025362972752303082
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00204918	0.025362972752303082
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303082
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.025362972752303082
GREENBERG DYSPLASIA	0.00204918	0.025362972752303082
SYNDACTYLY, TYPE V	0.00204918	0.025362972752303082
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.025362972752303082
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.025362972752303082
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00204918	0.025362972752303082
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.025362972752303082
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00204918	0.025362972752303082
FEINGOLD SYNDROME	0.00204918	0.025362972752303082
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.025362972752303082
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.025362972752303082
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303082
HEART-HAND SYNDROME TYPE 3	0.00204918	0.025362972752303082
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.025362972752303082
CAREY-FINEMAN-ZITER SYNDROME	0.00204918	0.025362972752303082
PERIPHERAL DYSOSTOSIS	0.00204918	0.025362972752303082
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.025362972752303082
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.025362972752303082
CHARLIE M SYNDROME	0.00204918	0.025362972752303082
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.025362972752303082
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.025362972752303082
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.025362972752303082
PROXIMAL SYMPHALANGISM	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.025362972752303082
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.025362972752303082
ROIFMAN SYNDROME	0.00204918	0.025362972752303082
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.025362972752303082
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.025362972752303082
OPSISMODYSPLASIA	0.00204918	0.025362972752303082
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.025362972752303082
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.025362972752303082
ISOLATED BRACHYCEPHALY	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.025362972752303082
MULTIPLE METAPHYSEAL DYSPLASIA	0.00204918	0.025362972752303082
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.025362972752303082
DESBUQUOIS DYSPLASIA 1	0.00204918	0.025362972752303082
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.025362972752303082
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.025362972752303082
THANATOPHORIC DYSPLASIA TYPE 2	0.00204918	0.025362972752303082
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.025362972752303082
OROFACIODIGITAL SYNDROME TYPE 1	0.00204918	0.025362972752303082
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.025362972752303082
ATELOSTEOGENESIS, TYPE I; AO1	0.00204918	0.025362972752303082
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.025362972752303082
LAURENCE-MOON SYNDROME	0.00204918	0.025362972752303082
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303082
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00204918	0.025362972752303082
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.025362972752303082
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.025362972752303082
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.025362972752303082
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.025362972752303082
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.025362972752303082
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.025362972752303082
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.025362972752303082
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.025362972752303082
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.025362972752303082
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.025362972752303082
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.025362972752303082
PYCNODYSOSTOSIS	0.00204918	0.025362972752303082
ROBERTS SYNDROME; RBS	0.00204918	0.025362972752303082
FRONTORHINY	0.00204918	0.025362972752303082
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.025362972752303082
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.025362972752303082
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303082
HYPOCHONDROPLASIA	0.00204918	0.025362972752303082
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.025362972752303082
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303082
URBAN-ROGERS-MEYER SYNDROME	0.00204918	0.025362972752303082
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.025362972752303082
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.025362972752303082
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303082
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303082
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.025362972752303082
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.025362972752303082
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.025362972752303082
2Q37 MONOSOMY	0.00204918	0.025362972752303082
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.025362972752303082
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.025362972752303082
WEILL-MARCHESANI SYNDROME	0.00204918	0.025362972752303082
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995137
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995137
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995137
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.006752394243995137
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995137
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.006752394243995137
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995137
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995137
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995137
POTOCKI-SHAFFER SYNDROME	0.000545554	0.006752394243995137
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.006752394243995137
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995137
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995137
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995137
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995137
JOUBERT SYNDROME 6	0.000545554	0.006752394243995137
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995137
12Q14 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995137
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.006752394243995137
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995137
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995137
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.006752394243995137
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.006752394243995137
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.006752394243995137
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.006752394243995137
SCHINDLER DISEASE, TYPE I	0.000545554	0.006752394243995137
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.006752394243995137
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.006752394243995137
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995137
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.006752394243995137
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.006752394243995137
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995137
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995137
WOLMAN DISEASE	0.000545554	0.006752394243995137
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995137
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995137
CURRARINO SYNDROME	0.000545554	0.006752394243995137
LARSEN-LIKE SYNDROME	0.000545554	0.006752394243995137
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995137
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995137
JOUBERT SYNDROME 2	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995137
FRIAS SYNDROME	0.000545554	0.006752394243995137
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995137
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995137
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995137
KAGAMI-OGATA SYNDROME	0.000545554	0.006752394243995137
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995137
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995137
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.006752394243995137
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.006752394243995137
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995137
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995137
ROTHMUND-THOMSON SYNDROME	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995137
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995137
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.006752394243995137
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995137
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.006752394243995137
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995137
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.006752394243995137
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995137
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.006752394243995137
MEND SYNDROME; MEND	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995137
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995137
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995137
BRESEK SYNDROME	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.006752394243995137
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995137
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995137
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.006752394243995137
KEUTEL SYNDROME	0.000545554	0.006752394243995137
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.006752394243995137
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995137
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.006752394243995137
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995137
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995137
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995137
NETHERTON SYNDROME; NETH	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.006752394243995137
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.006752394243995137
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995137
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995137
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995137
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.006752394243995137
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995137
3MC SYNDROME 2	0.000545554	0.006752394243995137
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995137
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995137
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995137
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995137
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995137
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995137
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.006752394243995137
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995137
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995137
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995137
OROTIC ACIDURIA	0.000545554	0.006752394243995137
DPAGT1-CDG	0.000545554	0.006752394243995137
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995137
NAVAJO NEUROHEPATOPATHY	0.000545554	0.006752394243995137
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995137
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995137
ELEJALDE DISEASE	0.000545554	0.006752394243995137
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.006752394243995137
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995137
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995137
TAY-SACHS DISEASE	0.000545554	0.006752394243995137
ALG3-CDG	0.000545554	0.006752394243995137
CURRY-JONES SYNDROME	0.000545554	0.006752394243995137
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.006752394243995137
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995137
CDAGS SYNDROME	0.000545554	0.006752394243995137
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.006752394243995137
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995137
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.006752394243995137
ALG1-CDG	0.000545554	0.006752394243995137
RIGID SPINE SYNDROME	0.000545554	0.006752394243995137
SALLA DISEASE	0.000545554	0.006752394243995137
ALG6-CDG	0.000545554	0.006752394243995137
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995137
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995137
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995137
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995137
FRONTOOCULAR SYNDROME	0.000545554	0.006752394243995137
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.006752394243995137
PHACE ASSOCIATION	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995137
LIG4 SYNDROME	0.000545554	0.006752394243995137
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995137
BIOTINIDASE DEFICIENCY	0.000545554	0.006752394243995137
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995137
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.006752394243995137
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995137
SCHIZENCEPHALY	0.000545554	0.006752394243995137
TARP SYNDROME; TARPS	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995137
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995137
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.006752394243995137
KETOADIPICACIDURIA	0.000545554	0.006752394243995137
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995137
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995137
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995137
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995137
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995137
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995137
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995137
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995137
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.006752394243995137
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.006752394243995137
CODAS SYNDROME	0.000545554	0.006752394243995137
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995137
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995137
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995137
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995137
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995137
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.006752394243995137
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995137
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.006752394243995137
COACH SYNDROME	0.000545554	0.006752394243995137
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.006752394243995137
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995137
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995137
ISOLATED PLAGIOCEPHALY	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.006752394243995137
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.006752394243995137
FARBER DISEASE	0.000545554	0.006752394243995137
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.006752394243995137
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.006752394243995137
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.006752394243995137
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995137
TRISOMY 18	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995137
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.006752394243995137
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995137
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.006752394243995137
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.006752394243995137
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.006752394243995137
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995137
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995137
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.006752394243995137
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995137
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.006752394243995137
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995137
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.006752394243995137
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.006752394243995137
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995137
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.006752394243995137
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995137
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.006752394243995137
PROPIONIC ACIDEMIA	0.000545554	0.006752394243995137
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.006752394243995137
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.006752394243995137
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995137
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.006752394243995137
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995137
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.006752394243995137
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.006752394243995137
OPTIC ATROPHY 11; OPA11	0.000545554	0.006752394243995137
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995137
LISSENCEPHALY 8; LIS8	0.000545554	0.006752394243995137
GRISCELLI SYNDROME	0.000545554	0.006752394243995137
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.006752394243995137
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995137
JOUBERT SYNDROME 28	0.000545554	0.006752394243995137
JOUBERT SYNDROME 27	0.000545554	0.006752394243995137
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995137
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.006752394243995137
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.006752394243995137
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.006752394243995137
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995137
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995137
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995137
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.006752394243995137
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.006752394243995137
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995137
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995137
AL KAISSI SYNDROME; ALKAS	0.000545554	0.006752394243995137
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995137
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995137
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995137
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995137
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.006752394243995137
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.006752394243995137
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995137
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.006752394243995137
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995137
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995137
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995137
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995137
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.006752394243995137
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995137
HYDRANENCEPHALY	0.000545554	0.006752394243995137
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995137
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995137
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995137
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995137
CUTIS LAXA	0.000545554	0.006752394243995137
OPTIC PATHWAY GLIOMA	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995137
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995137
GERODERMA OSTEODYSPLASTICA	0.000545554	0.006752394243995137
GERMAN SYNDROME	0.000545554	0.006752394243995137
PERLMAN SYNDROME	0.000545554	0.006752394243995137
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995137
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995137
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.006752394243995137
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995137
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.006752394243995137
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995137
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995137
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995137
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995137
XP21 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.006752394243995137
N SYNDROME	0.000545554	0.006752394243995137
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.006752394243995137
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.006752394243995137
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995137
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995137
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995137
ICF SYNDROME	0.000545554	0.006752394243995137
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995137
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
MICRO SYNDROME	0.000545554	0.006752394243995137
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.006752394243995137
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995137
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995137
1Q44 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995137
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995137
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995137
EAST SYNDROME	0.000545554	0.006752394243995137
PENTASOMY X	0.000545554	0.006752394243995137
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995137
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995137
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.006752394243995137
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.006752394243995137
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995137
AYMÉ-GRIPP SYNDROME	0.000545554	0.006752394243995137
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995137
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995137
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995137
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995137
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.006752394243995137
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.006752394243995137
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.006752394243995137
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.006752394243995137
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995137
XQ21 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995137
TOLUENE EMBRYOPATHY	0.000545554	0.006752394243995137
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.006752394243995137
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995137
MEVALONIC ACIDURIA	0.000545554	0.006752394243995137
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.006752394243995137
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995137
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995137
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995137
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA	0.000545554	0.006752394243995137
DISTAL TRISOMY 6P	0.000545554	0.006752394243995137
MOSAIC TRISOMY 14	0.000545554	0.006752394243995137
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.006752394243995137
TRISOMY 12P	0.000545554	0.006752394243995137
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.006752394243995137
DEXTROCARDIA	0.000545554	0.006752394243995137
HEREDITARY OROTIC ACIDURIA	0.000545554	0.006752394243995137
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995137
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995137
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.006752394243995137
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.006752394243995137
STEEL SYNDROME; STLS	0.000545554	0.006752394243995137
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.006752394243995137
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995137
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995137
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995137
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995137
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995137
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995137
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995137
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995137
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995137
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.006752394243995137
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.006752394243995137
JOUBERT SYNDROME 21	0.000545554	0.006752394243995137
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995137
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.006752394243995137
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.006752394243995137
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995137
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995137
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995137
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.006752394243995137
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995137
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995137
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.006752394243995137
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995137
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995137
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995137
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995137
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995137
NOONAN SYNDROME 6; NS6	0.000545554	0.006752394243995137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995137
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.006752394243995137
NETHERTON SYNDROME	0.000545554	0.006752394243995137
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.006752394243995137
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.006752394243995137
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.006752394243995137
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995137
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.006752394243995137
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995137
JOUBERT SYNDROME 8	0.000545554	0.006752394243995137
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995137
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995137
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.006752394243995137
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995137
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995137
JOUBERT SYNDROME 7	0.000545554	0.006752394243995137
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.006752394243995137
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995137
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.006752394243995137
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.006752394243995137
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.006752394243995137
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.006752394243995137
JOUBERT SYNDROME 15	0.000545554	0.006752394243995137
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995137
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.006752394243995137
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995137
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995137
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.006752394243995137
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995137
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995137
LISSENCEPHALY 4	0.000545554	0.006752394243995137
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.006752394243995137
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995137
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995137
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995137
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.006752394243995137
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995137
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995137
EVEN-PLUS SYNDROME	0.000545554	0.006752394243995137
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995137
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995137
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995137
JOUBERT SYNDROME 26	0.000545554	0.006752394243995137
JOUBERT SYNDROME 25	0.000545554	0.006752394243995137
SECKEL SYNDROME 9; SCKL9	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.006752394243995137
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.006752394243995137
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995137
PHACE SYNDROME	0.000545554	0.006752394243995137
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
JOUBERT SYNDROME 24	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995137
SENIOR-LOKEN SYNDROME 9	0.000545554	0.006752394243995137
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995137
COG2-CDG	0.000545554	0.006752394243995137
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995137
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995137
MIRAGE SYNDROME; MIRAGE	0.000545554	0.006752394243995137
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995137
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995137
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995137
MEIER-GORLIN SYNDROME 7	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995137
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995137
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995137
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.006752394243995137
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995137
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.006752394243995137
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.006752394243995137
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.006752394243995137
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995137
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995137
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.006752394243995137
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.006752394243995137
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995137
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.006752394243995137
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995137
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995137
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995137
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995137
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995137
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.006752394243995137
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995137
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.006752394243995137
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995137
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.006752394243995137
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995137
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995137
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995137
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995137
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995137
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995137
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.006752394243995137
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.006752394243995137
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.006752394243995137
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995137
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.006752394243995137
